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Abstract 
Background: 
All research involving human participants should have ethical approval and informed 
consent. There is no recent evidence on the incidence of reporting of compliance with 
these ethical criteria in orthodontic journals, nor is there evidence on which factors 
predict the compliance of Randomised Controlled Trials (RCTs) with ethical approval 
and informed consent.    
Aims:   
This study aimed to: 
 Assess the number of Randomised Controlled Trials and Controlled Clinical Trials 
(CCTs) published in the American Journal of Orthodontics and Dentofacial 
Orthopedics, Angle Orthodontist, European Orthodontic Journal and Journal of 
Orthodontics (formerly British Journal of Orthodontics) between 1
st
 January 2001 and 
31
st
 December 2010.  
 Determine the number of these papers which recorded having obtained ethical 
approval and informed consent. 
 Determine the number of authors, number of centres, location, involvement of a 
statistician, year of publication and the presence of “random*” in either the title or 
abstract or body of the RCTs. 
 Determine whether the factors above influenced an RCT’s likelihood of having 
recorded ethical approval and informed consent. 
10 
 
 Determine the sensitivity of identifying RCTs in the four journals under consideration 
using various electronic search methods,  through a MEDLINE search via PubMed 
and Ovid, for publication type “RCT” and PubMed free text search for “random* 
AND orthodontic”. Compare results with previously published findings.   
 Compare the electronic search methods with handsearching as the gold standard.  
Design:   
Retrospective observational study. 
Data Sources:   
Articles published between 1
st
 January 2001 and 31
st
 December 2010 in the American Journal 
of Orthodontics and Dentofacial Orthopedics (AJODO), The Angle Orthodontist (AO), 
European Journal of Orthodontics (EJO) and Journal of Orthodontics (JO) (formerly British 
Journal of Orthodontics).  
Sample:  
All CCTs and RCTs published in the AJODO, AO, EJO and JO between 1
st
 January 2001 and 
31
st
 December 2010 were included.  
Method:  
 RF passed the Cochrane Oral Health Group Handsearching test.  
 A search of all CCTs and RCTs published in the AJODO, AO, EJO and JO between 
1
st
 January 2001 and 31
st
 December 2010 was performed. 
11 
 
 The RCTs and CCTs were assessed for a statement that the paper had obtained ethical 
approval and informed consent.  
 The RCTs were further analysed to determine the following criteria: publication 
journal, number of authors, number of centres, location of origin, involvement of a 
statistician, year of publication, and whether random* was in the title or abstract or 
body of the article. 
Results: 
Over the ten year period 4748 articles were identified, of which 218 reported RCTs and 89 
CCTs. RCTs comprised 4.6% and CCTs 1.9% of all articles published over that time period. 
Of the CCTs, 36% had reported both ethical approval and informed consent and 39.3% had 
neither. Of the RCTs, 48.6% had reported both ethical approval and informed consent and 
27.1% had neither.  
Factors associated with an RCT reporting that ethical approval and informed consent had 
been obtained were: 
Number of authors (p<0.001), Random* in Title (p<0.001), Random* in Abstract not Title 
(p<0.001), Location of origin (p=0.001), Year of publication (p=0.003), The journal of 
publication (p=0.004) and Number of centres (p=0.008). 
A logistic regression analysis showed that the most significant indicators of ethical approval 
and informed consent having been reported were: 
Publication in the JO (p=0.018), 6 or more authors (p<0.001), Random* in the abstract not 
title (p=0.004) and Publication after 2004 (p=0.001). 
12 
 
A comparison of handsearching with three commonly used electronic search methods showed 
that handsearching was more accurate. Ovid was significantly less sensitive than PubMed 
(OR 8.43, 95% CI 5.48, 12.97) missing 157 RCTs (72.0%), while PubMed missed 51 
(23.4%). The free text PubMed search, using the terms orthodontic AND random*, was the 
most sensitive missing 45 RCTs (20.6%); though this was not statistically significant (OR 
0.85, 95% CI 0.54, 1.34)  
Only 56 RCTs (25.7%) were found by all 3 electronic searches. However 37 RCTs (17%) 
were not identified by any of the electronic search strategies. 
Conclusions: 
The reporting of whether ethical approval and informed consent had been obtained are 
inadequately reported in papers reporting orthodontic RCTs and CCTs. RCTs published in 
the JO, those with 6 or more authors, with Random* in the abstract but not the title and those 
published after 2004, were most likely to have reported that ethical approval and informed 
consent had been obtained. Handsearching was more accurate than electronic searching and 
PubMed more sensitive than Ovid. 
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Chapter 1: Introduction  
Research ethics are regarded as ‘the more or less deliberate and systematic consideration of 
moral problems arising in connection with the conduct and consequences of scientific 
research’.1  Ethical approval and informed consent are essential aspects of any research 
involving human subjects, as they are concerned with the most basic of human rights, namely 
the right to life, liberty and security of person, together with freedom from inhuman and 
degrading treatment
2
  (Articles 3 and 5 of United Nations’ Declaration of Human Rights).  
Scientific research embodies these concepts in the code of ethics on human experimentation 
known as the Declaration of Helsinki.
3
 
Previous orthodontic research by Harrison
4
 indicated a low level of compliance with both 
ethical approval and informed consent for both orthodontic RCTs and CCTs.  In this thesis I 
examined orthodontic Controlled Clinical Trials (CCTs) and Randomised Controlled Trials 
(RCTs), published over the past ten years  in the American Journal of Orthodontics and 
Dentofacial Orthopedics (AJODO), the Angle Orthodontist (AO), the European Journal of 
Orthodontics (EJO) and the Journal of Orthodontics (JO), (formerly the British Journal of 
Orthodontics (BJO)) and evaluated whether the RCTs and CCTs published in these journals 
fulfill the criteria specified by the Declaration of Helsinki, namely having obtained ethical 
approval and informed consent.  I also investigated the RCTs further to identify predictors of 
satisfying ethical criteria. These predictors included the number of authors and research 
centres involved, any use of a statistician, year of publication and the country of origin of the 
study.   
In this era of Evidence Based Medicine (EBM), clinical decisions increasingly require a 
strong basis in, and support from, scientific evidence. The pinnacle of evidence is considered 
14 
 
to be a meta-analysis of RCTs.
5
 These meta-analyses require the identification and 
consideration of all relevant studies for potential inclusion so as to reduce inter-trial bias. 
Published guidelines on meta-analyses identify a common search strategy, most often that 
developed for MEDLINE or a revision of same; such strategems often involve a combination 
of controlled vocabulary and free text terms.
6
 In addition, in this thesis I will assess the 
efficiency of locating RCTs on MEDLINE using various search methods and compare this to 
the gold standard of handsearching.  
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Chapter 2: Literature Review 
Principles of Ethics 
 
There are four principles of biomedical ethics: 
1. ‘Primum non nocere’ (first do no harm), is also known as non-malificence, as 
included in the Hippocratic Oath.
7
  
2. Beneficence – acting in a positive fashion, to improve a situation and in the best 
interests of your patients. 
3. Justice – all patients should be treated equally with fair apportioning of resources.  
4. Autonomy – the right of an individual to make informed decisions for themselves 
without pressure, according to their capacity. 
Dignity and honesty are also important ethical principles.  
Such ethical principles are obviously central to the provision of healthcare as well as 
research. Topical issues such as just allocation of expensive treatment on a background of a 
dearth of resources (the so-called “Postcode Lottery”), requests for voluntary euthanasia and 
the use of tissue from aborted foetuses, all pose ethical dilemmas which are examined 
through the medium of the four principles mentioned above. Many ethical questions in our 
clinical practice can only be answered by well performed and ethical research bearing in 
mind such mandates. Orthodontic research aims to develop and test effective, reliable and 
robust clinical treatments, therefore questions such as: “should treatment be provided early or 
late?”, “should it be delivered in one or two phases?”, “can functional appliances modify 
growth?”, can best be answered by well designed and ethical research. 
16 
 
What is research? 
 
Research is defined as “the attempt to derive generalisable new knowledge, including studies 
that aim to generate hypotheses as well as studies that aim to test them”.8  It is thus different 
from both clinical audit and service evaluation.  These are defined respectively as being 
“designed and conducted to produce information to inform delivery of best care”8 and 
“designed and conducted solely to define or judge current care”.8  
Each country has their own guidelines as to when ethical approval and informed consent are 
required.
9, 10
 European Union guidelines are common to all member states. 
Ethical Guidelines: History and the Law 
 
Contemporary research is strictly governed by several guidelines (Table 1.1), chief amongst 
which is the Declaration of Helsinki (DoH), promulgated by the World Medical Association 
(WMA).
3
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Table 1.1 Guidelines concerning the Protection of Human Participants. 
Nuremberg Code. 
11
 
Declaration of Helsinki – World Medical Association.12 
International Ethical Guidelines for Biomedical Research involving Human Subjects –
Council for International Organisations of Medical Sciences and the World Health 
Organisation.
13
 
Universal Declaration on Bioethics and Human Rights – United Nations Educational 
Scientific and Cultural Organisation.
14
 
Convention for the Protection of Human Rights and Dignity of the Human Being with regard 
to the Application of Biology and Medicine – Convention on Human Rights and 
Biomedicine, Council of Europe.
15
   
Uniform Requirements for Manuscripts to Biomedical Journals – International Committee of 
Medical Journal Editors.
16
 
Recommendations on Publication Ethics Policies for Medical Journals. – World Association 
of Medical Editors. 
17
 
Medical Research Guidelines- Human Tissue and Biological Samples for use in Research- 
Operational and Ethical Guidelines.-Medical Research Council.
18
 
Code of Conduct and Best Practice Guidelines for Journal Editors. – Committee on 
Publication Ethics (COPE) Council.
19
 
CONSORT (Consolidated Standards of Reporting Trials) statement for reporting of RCTs – 
CONSORT Group.
20
  
PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) – PRISMA 
Group.
21
 
 
These guidelines are issued by a number of authorities, from those involved in publishing, for 
example CONSORT and PRISMA, to International and National organisations. International 
organisation such as the UN’s Universal Declaration on Bioethics and Human Rights and 
World Medical Association’s Declaration of Helsinki. National organisations include the 
UK’s Medical Research Council’s Operational and Ethical Guidelines.  The International 
18 
 
Committee of Medical Journal Editors’ (ICJME’s) uniform requirements for manuscripts 
submitted to biomedical journals require that, 
 
“authors should indicate whether the procedures followed were in accordance 
with the ethical standards of the responsible committee on human 
experimentation (institutional and national) and with the Helsinki 
Declaration. If doubt exists whether the research was conducted in 
accordance with the Helsinki Declaration, the authors must explain the 
rationale for their approach and demonstrate that the institutional review 
body explicitly approved the doubtful aspects of the Study”.16  
 
Nearly 900 journals state that they have adopted the ICJME’s requirements.22 These 
guidelines all attempt to protect human subjects’ rights and autonomy, maintain ethical 
standards and ensure the integrity of biomedical research on human participants.  The 
requirements of the Declaration of Helsinki must be fulfilled when carrying out such 
research.   
An ethical attitude towards evidence-based research is not a modern phenomenon. Avicenna 
(Ibn Sîna, c. 980 – 1037) was one of the first to discuss concepts of ethical research and 
RCTs.
23
 His Canon in Medicine (Al-Qanun fil-Tib) explored the concepts of evidence-based 
medicine including RCTs.
24
 
In the early twentieth century, codes of ethics for research and the treatment of human 
subjects were introduced in countries such as Germany (1931)
25
 and the Soviet Union 
(1936).
26
 However, the main stimulus towards the development of a comprehensive statement 
of moral duties and ethical requirements in research was as a direct result of several infamous 
experiments performed in a variety of nations during the first half of the twentieth century. 
19 
 
This included Japan’s Unit 731, Australian mustard gas experimentation, human radiation 
trials, the Tuskegee Syphilis Study and Nazi Germany’s notorious experiments in the 
concentration camps.
7
 Dentistry moreover, is not immune from participation in unethical 
trials, The Vipeholm experiments, for example, involved the subjection of mentally 
handicapped subjects to large volumes of sugar so as to induce an experimental human model 
of caries.
27,
 
28
  
The public airing of such heinous experiments helped provide an impetus towards the 
conceptualisation of the “dignity” of the human body and its existence. This tenet became 
more closely defined with reference to the Medical Sciences and research ethics, taking a 
central role in the international reaction to the atrocities of World War Two.  The Universal 
Declaration of Human Rights (1948)
29
 and International Covenant on Civil and  Political 
Rights (1966)
2
 both employ the term “dignity” as defining the status of humans,30 something 
rather different from the traditional English meaning of the term. Following the Latin word 
Dignitas, dignity referred to rank in society, honour and importance, as in the famous 
Shakespeare prologue,  
“Two households, both alike in dignity,  
    In fair Verona, where we lay our scene...”31  
Contemporary understanding of a “dignity” of the human state was deeply influenced by the 
stance of the 18
th
 century philosopher Immanuel Kant, who differentiated between dignity 
and price, or absolute and relative value:  
 
20 
 
“In the kingdom of ends everything has either a price or a dignity. Whatever has a 
price can be replaced by something else as its equivalent; on the other hand, what is 
above all price, and therefore admits of no equivalent, has a dignity.”32  
 
Thus a human being is intrinsically priceless and therefore has dignity but no price, in 
contrast to an inanimate object which has a price but no dignity.  
This moral conceptualisation has led bioethicists throughout the twentieth and twenty first 
centuries to consider the human body as the locus of absolute dignity.  Thus, this dignity 
involves the protection and preservation of its integrity, with dignity being destroyed if any 
part of the body is assigned a monetary value and thus rendered alienable and transferable.  
For example, participation in clinical trials or organ donation for financial gain.  
Direct payment for human tissue, blood, organs and suchlike is not permissible in Western 
Europe and some of the Industrialised Commonwealth countries (Canada, Australia, New 
Zealand); the human tissue must be donated.
33, 34
 Sperm donation is an exception to this rule, 
where donors are often paid “expenses”.  A recent recommendation made by the Nuffield 
Council on Bioethics proposed a pilot scheme in which the funeral expenses of organ donors 
are paid for by the NHS.
35
  If this were to be successful it may be a more ethical method of 
encouraging an increase in subscription to the Organ Donation Register.  Paying for the 
funeral expenses would be ethical as no harm would come to the donor and it would be a 
form of recognition of such a sacrifice from society, further reinforcing the value of these 
voluntary donations.  Currently the organ donation requests of approximately 10% of organ 
donors are rejected by their families at the time of death; such recognition may perhaps 
reduce this number. Unlike most other parts of the world, in the USA it is permissible to sell 
21 
 
blood, creating a mixture of voluntary and paid blood collection services.  There is evidence 
that blood from paid donors has a higher risk of being infected than that provided by donors 
gratis, as the motivation for giving blood is different and less likely to be given for purely 
altruistic reasons.
36, 37  
Introduction of the Nuremberg Code and Development of the 
Declaration of Helsinki 
 
The Nuremberg Code was introduced in 1947 as part of the Nuremberg Trials which 
comprised part of a series of military tribunals, held by the Allied Forces at the end of World 
War II. These trials were presided over by a cohort of judges from the victorious Allied 
powers, British, French, USA and Soviet Union and passed judgement on major Axis 
political, economic and military figures who were accused of war crimes including Speer, 
Donitz and Goering amongst others. Those doctors who had been accused of torturous and 
murderous human experimentation in the concentration camps were also tried in separate 
proceedings.
38
  The primary ideology of the doctors’ trials was that although these were 
murder trials, they also considered the role of “Hippocratic” values and ethics, holding up the 
role of the Medical Professional as one who implicitly abides by the concept of the 
“Hippocratic Oath” and “Primum Non Nocere”.39  As a result of the judgement against these 
doctors, the Nuremberg Code was introduced. This enshrined twelve principles, including 
informed voluntary consent, that the participant was at liberty to end his/her role in the 
experiment at will and that the experiment be carried out in such a way as to avoid all 
unnecessary physical and mental suffering and injury.
7, 40
  The requirement of informed 
consent has been accepted worldwide and is articulated in international law in Article 7 of the 
United Nations International Convention on Civil and Political Rights (1966).
2, 41
  In 1947 the 
newly formed World Medical Association (WMA) endorsed a modernized version of the 
22 
 
Hippocratic Oath.
25
 Then in 1954, the WMA adopted the Resolution on Human 
Experimentation.  Following on from this, the Declaration of Helsinki (DoH) was developed 
by the World Medical Association (WMA) in 1964.  The DoH developed ten of the twelve 
ethical principles of the Nuremberg Code and allied them to the Declaration of Geneva, thus 
specifically addressing clinical research.
42
 One of the two areas which were more clearly 
defined in the transfer from the Nuremberg Code to the Declaration of Helsinki was that of 
informed consent.  The Nuremberg Code states that: “the voluntary consent of the human 
subject is absolutely essential”, this is different to the Declaration of Helsinki, where consent 
can be given by a “legal guardian” in case of “legal incapacity” (Article II.1).  The following 
sentence was removed in the transition from the Nuremberg Code to the Declaration of 
Helsinki,  
 
‘During the course of the experiment the human subject should be at liberty to bring 
the experiment to an end if he has reached the physical or mental state where 
continuation of the experiment seems to him to be impossible’.38   
 
This was replaced with a somewhat similar statement in the Declaration of Helsinki, that the 
participant has the freedom to opt out of the experiment at any time and the investigator must 
“discontinue the research if in his or their judgement it may, if continued, be harmful to the 
individual”.12 
Since it was enacted in Helsinki in 1964, the Declaration has been regarded as “the most 
widely accepted guidance worldwide on medical research involving human subjects.”43 
Although the Declaration is not a legally binding document; it draws its authority from the 
degree into which it has influenced national legislation. Humans and Fluss referred to the 
importance of this document,  
23 
 
 
“Even though the Declaration of Helsinki is the responsibility of the World Medical 
Association, the document should be considered the property of all humanity".
44
   
 
The Declaration of Helsinki has since undergone six revisions, most recently in 2008, 
including “independent committees” (Article I.2) to oversee the implementation of the 
Declaration, which subsequently developed into research ethics committees. 
When is ethical approval required? 
 
The requirement for ethical approval varies from country to country.  In the European Union 
(EU) and United States of America (USA) ethical approval is required from an ethics board 
for all research involving humans or animals, as is the case for most countries.  However in 
Canada, a research ethics board review is only required if the research is funded by an 
organisation which requires ethical review, for example, a University or in the case of clinical 
trials on experimental drugs.  If the researcher is able to obtain funds through other methods 
it is possible to avoid the ethical review board.
45
  
In the United Kingdom (UK), the National Research Ethics Service (NRES formerly 
COREC) has overall responsibility for determining that ethical approval is obtained for that 
research which requires it and that a log is kept of all research involving human 
participants.
46
 
Ethical approval in the UK must be obtained for any research involving humans, 
encompassing the testing of new interventions on participants, research on human tissue and 
the review of personal data such as radiographs.
10
    
24 
 
Ethical REVIEW is necessary for research in many situations:
46
 
1. “ Potential research participants identified from, or because of, their past 
or 
present use of the services...(including services provided under 
contract with the private or voluntary sectors), including participants 
recruited through these services as healthy controls; 
2.  Potential research participants identified because of their status as 
relatives or carers of past or present users of these services; 
3. Collection of tissue (i.e. any material consisting of or including human 
cells) or information from users of these services; or 
4. Use of previously collected tissue or information from which individual 
past or present users of these services could be identified, either directly 
from that tissue or information, or from its combination with other tissue 
or information in, or likely to come into, the possession of someone to 
whom the tissue or information is made available.” 
5. “Xenotransplantation (i.e. putting living cells, tissue or organs from 
animals into people), which, as a matter of Government policy, is 
recommended to take place in a controlled research context, carried out 
with a research protocol approved by a REC within the UK Health 
Departments’ Research Ethics Service; 
6. Health-related research involving prisoners, for which the National 
Offender Management Service, Scottish Prison Service and Northern 
Ireland Prison Service require review by a REC as well as compliance 
with their own approval procedures;  
25 
 
7. Social care research projects funded by the Department of Health, which 
must always be reviewed by a REC within the Research Ethics Service for 
England”. 
Informed Consent 
 
Informed consent is required from all human participants, including when their data or tissues 
are being utilised, as required by the Declaration of Helsinki. As mentioned previously, 
consent is to be obtained personally if at all possible but it is acceptable for consent to be 
given by proxy in specific circumstances.  
For participants in clinical trials there are statutory requirements for their informed consent.  
These regulations are set out in Schedule 1 of the Medicines for Human Use (Clinical Trials 
Regulations) 2004.
47
  These regulations transposed the European Clinical Trials Directive 
(EC2001/20)
48
 into UK law.  The European Clinical Trials Directive gives clear guidance 
concerning informed consent: 
“A person gives informed consent to take part in a clinical trial only if his decision: 
a. Is given freely after that person is informed of the nature, significance, 
implications and risks of the trial. 
 and  
b. Either: 
(i) Is evidenced in writing, dated and signed, or otherwise marked, by that 
person so as to indicate his consent. 
26 
 
Or: 
(ii) If the person is unable to sign or to mark a document so as to indicate his 
consent, is given orally in the presence of at least one witness and 
recorded in writing.”47 (Paragraph 3(1)) 
The same definition applies whenever informed consent is given, whether by a person with 
parental responsibility or a legal representative, on behalf of the trial subject. 
Informed consent in adults with capacity also requires further conditions to be met: 
1. “The subject has had an interview with the investigator, or another member of the 
investigating team, in which he has been given the opportunity to understand the 
objectives, risks and inconveniences of the trial and the conditions under which it 
is to be conducted. 
2. The subject has been informed of his right to withdraw from the trial at any time.  
3. The subject has given his informed consent to taking part in the trial. 
4. The subject may, without being subject to any resulting detriment, withdraw from 
the clinical trial at any time by revoking his informed consent.  
5. The subject has been provided with a contact point where he may obtain further 
information about the trial”.47(Part 3) 
 
These EU policies operate in conjunction with UK Department of Health guidelines. First 
issued in 1964, these guidelines outlined rigorous consent procedures and have subsequently 
undergone numerous revisions, most recently in October 2000.  Furthermore, these guidelines 
have been supplemented by another publication in 2001, the Research Governance 
27 
 
Framework for Health and Social Care.  This explicitly places informed consent at the heart 
of ethical research and requires the review of research by ethics committees.  
For consent to be valid it must be freely given and informed.  The Declaration of Helsinki 
states the importance of adequate information about the investigation (Article 22) and the 
importance of voluntariness (Article 23).  The amount of information disclosed to 
participants must pass the “reasonable person” test.  This concept of the amount of 
information a “reasonable person” would require to give informed consent originated as a 
result of a Canadian Supreme Court case – Halushka versus University of Saskatchewan.49 In 
this case, Walter Halushka was a participant in a trial who consented to have an arterial 
catheter inserted under general anaesthetic. He was not informed that he might be exposed to 
unknown risks, nor was he advised that the anaesthetic drug being tested was experimental 
and had never been tested previously.  Furthermore, although he was advised that a catheter 
would be inserted into an artery in his arm, he was not informed that this catheter would then 
be advanced into his heart.  The anaesthetic was administered through the catheter directly 
into his heart, which unfortunately resulted in a cardiac arrest. It took approximately 90 
seconds for his chest to be opened so manual heart massage could be performed.  Despite 
successful resuscitation, he suffered a degree of hypoxic brain injury, with subsequent mental 
impairment.  In giving his summative assessment, the presiding judge, Justice Hall, stated 
that: 
 
“In my opinion the duty imposed upon those engaged in medical research. . .  To 
those who offer themselves as subject for experimentation . . .  Is at least as, if not 
greater than, the duty owed by the ordinary physician or surgeon to his patient.  
There can be no exceptions to the ordinary requirement of disclosure in the case of 
research as there may well be in ordinary medical practice . . . .  The example of risks 
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being properly hidden from a patient when it is important that he should not worry 
can have no application in the field of research.  The subject of medical 
experimentation is entitled to a full and frank disclosure of all the facts, probabilities 
and opinions which a reasonable man might be expected to consider before giving his 
consent.”49 (supra note 6 at 436)  
 
Thus, the researcher must give full and frank disclosure of all risks, rather than the usual 
assessment of balance of risk between probable effects of new treatment versus lack of 
treatment.  Justice Hall felt that all the risks that a “reasonable person” would wish to know 
must be raised and explained before enrolment.
50
 By settling the level of disclosure at that 
that a “reasonable person” would expect Justice Hall implicitly disregarded the option of 
therapeutic privilege as a justification for a lack of “full and frank disclosure”.  Therapeutic 
privilege being the legal doctrine which permits medical professionals to withhold 
information from their patients if it is deemed in the patient’s best interest to do so.51 
The amount of information disclosed must also be relevant to the individual person in their 
individual situation.  This point was introduced in the Reibl versus Hughes case, another 
Canadian case which was heard in the Canadian Supreme Court in 1980.
52
  
In this case a Mr Reibl, then 44 years old, underwent surgery to remove an occlusion in his 
left internal carotid artery.  The surgery was competently performed by a Mr Hughes, the 
surgeon.  However Mr Reibl suffered a major stroke either during the operation or 
immediately post-operatively.  This resulted in paralysis affecting the left side of his body 
and impotency.  Although he had formally consented to the operation, he claimed afterwards 
that he was not fully informed of the risks involved and therefore that his consent was not 
valid.  This was as Mr Hughes, the surgeon, had only discussed with the patient the risk of a 
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stroke if the surgery was not performed and had not informed him of the risk of stroke as a 
result of the operation. Mr Reibl was, at the time of his operation, eighteen months away 
from fulfilling the minimum eligibility criteria for a lifetime retirement pension and extended 
disability benefits from his employer.  He claimed that he would not have proceeded with the 
surgery had he known there was even a minimal risk associated with the procedure or at the 
very least he would have delayed the surgery, as his was not an emergency case, until he had 
received his full pension and disability benefits.  His legal team argued that this was not valid 
consent as he was not fully informed of all the risks.  The importance of the “reasonable 
person” test was summarised by the presiding judge, Judge Laskin: 
 
“What the doctor knows or should know that the particular patient deems relevant to 
a decision whether to undergo prescribed treatment goes equally to his duty of 
disclosure as do the material risks recognized as a matter of required medical 
knowledge. . . .  To allow expert medical evidence to determine what risks are 
material, and hence, should be disclosed and, correlatively, what risks are not 
material is to hand over to the medical profession the entire question of the scope of 
the duty of disclosure, including the question whether there has been a breach of that 
duty”52 (supra note 5 at 12-13) 
  
The concept of individuals giving informed consent, having received all relevant information 
pertinent to their individual situation, creates difficulties in designing consent forms for 
clinical trials.  Research consent forms are generally written for the entire group of 
participants rather than each individual.  Thus in order to provide all the information which is 
pertinent to each individual participant, at that point in time, a large amount of information 
must be included in the consent documents.  Consent documents have therefore increased in 
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length over time.
53
  Although participants are now provided with more information, this has 
not lead to increasing levels of knowledge.
54
  Understandable information contributes to 
increasing comprehension but only up to a certain optimal level.
55
  Thus, although strict 
levels of information disclosure means a greater volume of information is provided, 
53
  this 
increased volume of information does not result in a greater level of understanding beyond 
that certain optimum level for each person.  
Another problem with consent forms is their readability.  It is accepted that research 
documents should be written at level which would be understood by a thirteen to fourteen 
year old.
56
 However, this is generally not the case.  The vast majority of these consent forms 
are written at a literary level which exceeds the comprehension level of the general 
population.
57
  These overly technical and complicated consent forms may well simply 
frustrate the potential participant, either in terms of excessive length or complexity, leading to 
inappropriately given or withheld consent, including the signing of documents that 
participants have not actually read.
58
 Another development, complicating the readability of 
these consent forms is their use as legal tools by sponsoring companies, in order to 
demonstrate that they have consented for all possible risks.
59
  
Differing formats can have an effect on the readability of consent forms.
57
 Recent research in 
paediatric anaesthetics has demonstrated that using a more visual format, especially 
pictograms,
60
 leads to parents being better informed when consenting their children for 
research than those parents consented using text alone.
61
  Graphical presentation of risks and 
benefits are particularly beneficial in individuals with low numeracy at enhancing 
understanding and therefore improving informed consent.
62
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The right to autonomy is a central tenet of the Universal Declaration of Human Rights so that 
a sufficiently rational and mature patient may accept or reject medical treatment even if it 
would be pejorative to their own health; a Jehovah’s Witness may refuse a blood transfusion 
although such a course of action may result in their death. In UK law, any treatment without 
consent is assault known as the crime of Battery in UK law, as well as opening the culprit up 
to the civil tort of negligence. Two of the “Lords of Appeal in Ordinary”, chief justices in the 
House of Lords, in Chester v Afshar declared that a patient’s rights to autonomy and dignity 
must be accorded the highest priority by UK law
63
 (at paras 17 and 24).  Lord Steyn stated 
that in “....modern law, paternalism no longer rules”63 (at para 16).  However, in the UK, the 
onus of proof lies with the patient to prove that they did not consent to treatment.
64
   
Consent in Specific Circumstances  
 
A significant proportion of orthodontic research has focused on children, legally referred to 
as minors.  There are specified consent procedures for both minors and “incapacitated 
adults”, namely adults who are unable to consent for themselves.  These groups are 
specifically protected by the European Clinical Trials Directive and should not be included in 
trials if the same results could be obtained by using people capable of giving consent.
48
   
Yet there is a need for clinical trials involving children.  Children have developmental, 
physiological and psychological differences from adults and therefore age- and 
developmental-related research is important for their benefit.  Thus, it is important that 
research is carried out on medicinal products that may benefit children, for example 
vaccinations and orthodontic appliances which are generally provided in childhood and 
adolescence. Child specific research on drugs is also important to ensure that the drugs have 
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been appropriate tested and licenced for use in children. In 2003 the National Audit Office 
reported that up to 90 per cent of medicines prescribed to children in hospital were not 
licenced for that use.
65
 The EU introduced legislation in 2006 to help remedy this and ensure 
more drugs are tested and authorised for use in children.
66
 However the market for paediatric 
drugs is small and long-term follow-up of adverse effects is often required as the risks 
associated with paediatric treatments are generally higher.
67
 
As regards other groups incapable of giving consent for participation in studies of this nature, 
for example certain psychiatric patients or those suffering from advanced dementia, inclusion 
in clinical trials is even more restrictive.  In this situation, the medicinal products on trial 
should only be administered where there are grounds for assuming that the product will give 
the participant a direct benefit and outweigh the risks involved.  Generally, the participant’s 
legal guardian will need to provide written consent, in co-operation with the participant’s 
treating doctor, before participation in any trial.
68
  
Research ethics committees (RECs) have a specific statutory responsibility towards minors 
and incapacitated adults and must have a member with suitable expertise in these areas.  If 
they do not, then advice must be obtained on the clinical, ethical and psychosocial problems 
that may arise through this trial.
69
   
With regards to an incapacitated adult, the REC must have a member with professional 
expertise in both the treatment of the disease the trial relates to and also the treatment of the 
disease the participant is suffering from.  If such a member is not part of the REC then it 
again must obtain advice on the clinical, ethical and psychosocial problems that may result as 
a consequence of the trial.  There are specific procedures laid out for consulting such expert 
referees.
69
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Consent and Minors 
 
When consenting for research, the Medicines for Human Use (Clinical Trials) Regulations 
2004, applicable in England, Wales and Northern Ireland, define a minor as someone under 
the age of 16 years.
47
 When common law applies- all situations not covered by the 
Regulations- the law states that the age of majority is 18 years.
70
 However, whilst not 
considered to have fully reached adulthood, young people between the ages of 16 and 18 
years are assumed competent to give consent. No statute governs the rights of those under 16 
years to give consent for medical treatment or research. 
These regulations classify a minor as being a person under the age of 16 years for the 
purposes of giving or withholding consent independent of any adult guardian.  The 
regulations specify a hierarchy for determining who should be approached to give informed 
consent on behalf of a minor for their inclusion into a clinical trial. Table 1.2 lays out the 
hierarchy of who should provide informed consent for a minor. Ideally this consent should be 
given by a parent or person with parental responsibility. 
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Table 1.2 Hierarchy of informed consent for a minor.68  
 Person who may 
give consent 
Definition Commentary 
1 Parent A parent or person with parental 
responsibility. 
Should always be approached if available. 
2 Personal legal 
representative 
A person not connected with the conduct 
of the trial who is: 
(a) Suitable to act as the legal 
representative by virtue of their 
relationship with the minor, 
and  
(b) Available and willing to do so.  
May be approached if no person with parental responsibility 
can be contacted prior to the proposed inclusion of the 
minor, by reason of the emergency nature of the treatment 
provided as part of the trial. 
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3 Professional legal 
representative 
A person not connected with the conduct 
of the trial who is: 
(c) The doctor primarily 
responsible for the medical 
treatment of the minor,  
or 
(d) A person nominated by the 
relevant health care provider 
(e.g. An acute NHS Trust or 
Health Board) 
May be approached if no person suitable to act as a personal 
legal representative is available.  Informed consent must be 
given before the minor is entered into the trial. 
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Since 2004 there has been further legislation introduced, including the Blood Safety and 
Quality (Amendment) Regulations 2008.  On occasion, the treatment given to a minor as part 
of a trial may need to be provided urgently, if this is the case there may not be time to obtain 
written consent of either the person with parental responsibility or a legal representative.  As 
a result of this amendment minors can be entered into the trial and provided with the 
treatment under investigation without having first obtained informed consent.  There are 
however a number of caveats to this: 
 With regard to the nature of the trial and the case’s individual circumstances it would 
be necessary to take urgent action for the purpose of the trial, however 
 It is not reasonably practical to obtain informed consent prior to enrolling the subject 
 The action taken is in accordance with a procedure approved by the ethics committee. 
If a minor is recruited into a trial in an emergency situation without prior informed consent 
then informed consent must be obtained as soon as is reasonably possible.  If this consent is 
withheld, then the subject must be withdrawn from the trial.
68
 
In Scotland, the Clinical Trials Regulations also apply with a minor being defined as 
someone under the age of 16 years.  However Scottish statute makes legal provision for 
young people, where they are considered competent, to consent to medical procedures or 
treatment.  Those aged 16 and above are presumed to be competent until proven otherwise, 
they have the legal capacity to enter into any transaction, including, “....the giving by a 
person of any consent having legal effect.”71 Young people under 16 years can give legally 
binding consent if the medical practitioner believes them to be competent.  “....a person under 
the age of 16 years shall have legal capacity to consent on his own behalf to any surgical, 
medical or dental procedure or treatment where in the opinion of a qualified medical 
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practitioner attending him, he is capable of understanding the nature and possible 
consequences of the procedure or treatment.”71 Thus in Scotland a young person’s capacity 
allows them to refuse as well as consent to treatment. It is not entirely clear whether this 
Scottish statute also applies to research, however in the absence of specific guidance, the 
principles of the law relating to consent for procedures may reasonably be applied. However 
it must be remembered that the threshold for understanding relates to the complexity of the 
research being performed.
72
 
Gillick Competency 
 
Throughout the UK as a whole, minors, aged less than sixteen years can give consent if they 
are mature enough to have full understanding of what they are consenting to.  A child with 
such understanding is referred to as being “Gillick Competent”.  This concept arose as a 
result of a House of Lords ruling in 1985 based on the case Gillick v West Norfolk and 
Wisbech Area Health Authority (1985).  In 1982 Victoria Gillick took the health authority 
and the Department of Health and Social Security to court in an attempt to prevent doctors 
giving contraception advice or treatment to under sixteen year olds without the consent of 
their parents.  It was dismissed in the High Court, by Mr Justice Woolf.
73
  It then went to the 
Court of Appeal where this decision was reversed, finding in favour of Mrs Gillick.  In 1985 
it then went to the House of Lords and the Law Lords ruled in favour of the original 
judgement of Mr Justice Woolf.
74
   
“....whether or not a child is capable of giving the necessary consent will depend on 
the child’s maturity and understanding and the nature of the consent required.  The 
child must be capable of making a reasonable assessment of the advantages and 
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disadvantages of the treatment proposed, so the consent, if given, can be properly and 
fairly described as true consent.”74  
Gillick competency is assessed using Lord Scarman’s comments in his judgement of the case 
in the House of Lords.  His comments are often referred to as the test of “Gillick 
competency”75:  
“....it is not enough that she should understand the nature of the advice which is being 
given: she must also have a sufficient maturity to understand what is involved.” 
He also commented more generally on the rights of parents versus the rights of their children: 
“Parental right yields to the child’s right to make his own decisions when he reaches 
a sufficient understanding and intelligence to be capable of making up his own mind 
on the matter requiring decision.”  
Hitherto it has become common practice to describe an assessment of competency in terms of 
“Gillick competence” or the “Fraser guidelines” as though these were interchangeable.  
Contrary to this belief, despite arising out of the same case, the “Fraser guidelines” 
specifically addressed the issue of providing contraceptive advice or treatment without the 
knowledge of the patient’s parent, whereas “Gillick competency” refers to the set of 
circumstances which demonstrate that a particular child has capacity to give informed 
consent in a particular situation.
74
 Gillick competency is the primary doctrine with which 
competency in children is judged , whereas the Fraser guidelines are an adjunct to fuse 
Gillick competency with specific guidelines for children receiving contraceptive advice.
76
  
If a child refuses to consent and the parent believes they should have treatment a healthcare 
professional can over-ride the child’s lack of consent, thus in an orthodontic setting it would 
be possible for a clinician to provide orthodontic treatment to a minor even if it were against 
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the minor’s wishes. If a child wants treatment or an intervention, for example contraception, 
but the parent does not, then this treatment can be provided, assuming that the child has 
sufficient maturity to understand what is involved and asks for the treatment.  The healthcare 
professional is unable to share details of the child’s treatment with the parent unless the child 
allows it.
77
 
The Declaration of Helsinki guidance specifies that parental consent is required for all 
treatment in individuals under eighteen year of age, unless there is a clear reason why 
parental consent should not be given.  However, in the United Kingdom, the Family Law 
Reform Act 1969 provides for 16 and 17 year olds to consent to treatment independently.  
The Royal College of Paediatrics and Child Health states that Gillick Competency is 
acceptable when consenting for enrolment in clinical research.
78
  However, the question is 
raised as to whether children can consent to non-therapeutic research which is of no benefit to 
them.  The generally held opinion is that there are often large benefits to be gained from 
heavily controlled child research.  When the risk is minimal, parents can consent as long as 
the procedure is not against the child’s best interests.72  
Research Governance in the United Kingdom 
 
In the United Kingdom, research is monitored primarily by guidance rather than legislation. 
However, there have been various incidences over the past decade to undermine confidence 
in this method of regulation.  A prime example occurred in 2006, when six healthy 
volunteers, in a Phase I clinical trial at Northwich Park Hospital, had to be managed in 
Critical Care as at least four of the volunteers had suffered multiple organ failure.
79
  An 
independent review of the trial found the regulation system to be at fault, that, 
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“the pre-clinical development studies that were performed with TNG1412 did not 
predict a safe dose for use in humans, even though current regulatory requirements were 
met”.79  
 This incident was but one in a series of scandals undermining public and professional 
confidence in research regulation.  In 2000 allegations were made that research was carried 
out on new-born infants in a North Staffordshire hospital without parental consent, although 
little evidence emerged in support of these opinions.
80
 In 2001 a 24-year-old volunteer died in 
a clinical trial in Washington,
81
  while in Bristol and Liverpool there have been scandals 
regarding the retention of children’s body parts post-mortem without parental knowledge or 
consent.
82
     
Legal aspects in the United Kingdom 
 
In UK law (England and Wales) there is considerable guidance however, there is limited 
legislation governing the ethical aspects of clinical research.  From a legal point of view, 
there are four main issues covering research and the ethics of research: 
 
1. Is there a need for further statutory regulation of clinical research? 
2. Is there true informed consent in clinical research? 
3. Conflicts between confidentiality and research. 
4. What degree and avenue of legal redress is appropriate in the case of injury acquired 
during the research? 
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In the United Kingdom, responsibility for clinical research in the NHS is shared by NHS 
research ethics committees (RECs) and local NHS Research and Development 
management.
83
   
Ethical Approval and the Law 
 
In the UK, if a research team fails to apply for ethical approval they are not breaking the law, 
unlike in USA.
84
 This leaves an area of uncertainty as to whether the possibility of 
disciplinary action by an employing NHS Trust is enough to regulate this area sufficiently.  
The same is true of research carried out outside the NHS, as the GMC and other professional 
bodies potentially consider that carrying out research without appropriate ethical approval is 
ground for “serious professional misconduct”.  Royal College of Physicians’ Guidelines state 
that,  
“All medical research involving human subjects should undergo ethical review before 
it commences, in accordance with the principles that investigators should not be the 
sole judge of whether their research raises significant ethical issues”.85  
Research Ethics Committees have a “Duty of Care” and therefore, direct legal responsibilities 
towards those taking part in research.  
UK research guidance is supplemented by European Union law, including the European 
Clinical Trials Directive which has been law as of 2004. 
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Research Governance in the European Union 
 
EU law takes precedent over any laws introduced by member states.  For matters under the 
jurisdiction of the Treaty of Rome and subsequent treaties, most notably the Treaty of 
Amsterdam, the EU has the power to make laws affecting all member states.  This is done 
either via regulations or directives.  Regulations immediately become law in each member 
state, whereas directives oblige each government to enact the directive in local law, which in 
the UK manifests itself as an Act of Parliament.  There are two main European Directives 
affecting ethics in research, namely the European Union Clinical Trials Directive 2001/20/EC 
(EUCTD)
48
 and Good Clinical Practice Directive 2005/28 (GCP).
86
  The EUCTD was 
enshrined into EU law in 2001 and became law in the UK with the Medicines for Human Use 
(Clinical Trials) Regulations 2004.
47
  The aims of the EUCTD were to improve both the 
safety and efficacy of EU clinical trials.  It strives to achieve these aims by: 
1. Providing greater protection to subjects participating in clinical trials. 
2. Increasing the number of patients entered into clinical trials. 
3. Improving the efficiency of trial implementation. 
4. Ensuring quality of conduct. 
5. Harmonising regulation and conduct of clinical trials throughout Europe. 
6. Ensuring best practice in ethical review and regulatory procedures. 
Other aims were to improve the competitiveness of European research and apply to both 
commercial and investigator research.  
Despite the EUCDT’s laudable aims, even prior to its introduction, the academic community 
was expressing its concerns about the EUCDT, such as the potential adverse effects on 
translational research in particular,
87
 upon which a negative impact has been demonstrated.
88
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A key aim in the EUCDT was to introduce harmonisation in the application for research 
ethics across the EU.  Unfortunately, this did not materialise, resulting in excessively 
complex organisation required for multicentre trials involving different European countries.
89
 
Thus, trials are taking longer to set up and becoming more expensive to run,
90
 highlighting a 
huge “Achilles’ Heel” in EU research. Based on figures prior to the EU enlargement in 2004, 
the level of funding for non-commercial research was five times higher per head of capita in 
the USA than the EU.
91
 Forecasts and surveys have indicated a 30-50% drop in the number of 
new non-commercial clinical trials started in the EU between 2004-2005.
92
 This creates 
worrying concerns about the future of Europe’s non-commercial research. 
Publication Bias 
Studies showing positive findings are more likely to be published.
93
 Studies showing positive 
findings are also important for drug approval by the FDA.  For a drug to be approved by the 
FDA Drug companies are obliged to provide two trials showing a statistical difference 
between the drug and a placebo, though it is not necessary to show a clinical difference 
between treatments.  Kirsch et al
94, 95
 performed a meta-analysis of clinical trials of anti-
depressants comparing antidepressants with placebos.
95
 This meta-analysis demonstrated a 
placebo response of 75% of the active drug response. The correlation between the placebo 
and active drug was 0.9. These findings were supported by similar results from the USA’s 
Agency for Healthcare Policy and Research which found approximately a 20% drug-placebo 
difference in response rates i.e. 30-50% in an intention to treat meta-analysis of published 
antidepressant RCTs .
96
 Drug companies are required to submit all trials involving a 
particular drug to the FDA as part of their NDA (New Drug Application) but this research is 
not required to be published as it is considered proprietary, though it is subject to the 
Freedom of Information Act. This study was then followed up in 2010
94
 when a Freedom of 
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Information request acquired the information sent by various drug companies to the FDA as 
part of the drug approval process.  The difference demonstrated here between drug and 
placebo was smaller than in the published data.  Again, similar findings were reported 
elsewhere.
97
    
Various registers have been introduced to make it more difficult not to publish negative trials 
and ensure that the published paper reports on what the trial was designed to test rather than 
“data dredging” to find something positive to publish. This is important because, based on the 
normal p value of 0.05, one out of every twenty measurements will be positive by chance.  
One such clinical trial registry is www.ClinicalTrials.gov, run by the USA’s National Library 
of Health (NLM) at the National Institutes of Health.  It was established in 1999 and is the 
world’s largest trials registry holding registrations from over 93,000 trials from over 170 
countries.  The aim of the registry was not only to make it more difficult to manipulate or 
selectively publish data but also to allow patients to find out about experimental treatments 
and possibly enrol in these trials.  In 2007, its range was expanded by the FDA requiring the 
sponsors of all drug, device and biological trials to register their studies on initiation (with the 
exception of Phase 1 Trials).  In 2005, the International Committee of Medical Journal 
Editors began the requirement that a trial be registered before it began recruiting patients thus 
creating a record of planned outcomes prior to the commencement of the study.  This 
requirement was necessary for a subsequent paper to be considered for publication.  A recent 
report looking at outcomes of trials registered on www.ClinicalTrials.gov found industry 
sponsored trials reported positive findings 85% of the time compared to 50% for government 
funded trials and 72% funded by non-profit or non-federal organisations.  Amongst these 
non-profit/non-federal trials, those with drug industry connections were more likely to report 
positive outcomes than those without (85% versus 61%).
98
  In addition to statistically 
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significant differences between positive and negative findings, there was also a significant 
difference with regards to when the research was published.  Drug company sponsored trials 
were least likely to be published within two years of study completion at 32%, whereas 54% 
of government trials and 56% of purely non-profit/non-federal trials were published within 
two years.
98
   There is also the publication bias of studies not being published, this was as 
demonstrated to great effect in a meta-analysis by MacLean et al, examining the relative risk 
of dyspepsia from NSAIDs.  Amongst the 37 trials described in the FDA review, only one 
was published in a peer reviewed journal.
99
 However in this case no meaningful difference 
was found between the published and unpublished studies.  Yet there were large differences 
in appropriate methods of randomisation and blinding between the published and unpublished 
studies. This may perhaps be a reflection of the different requirements for submission to peer 
reviewed journals and the FDA.  Thus, unlike the work by Thase and Kirsch discussed 
previously, there were minimal differences between the published and unpublished clinical 
trials. MacLean also draws attention to the fact that all 37 trials examined in this analysis 
were sponsored by the pharmaceutical industry and thus the quality of their methodology 
could not be compared to non-pharmaceutical sponsored trials.
99
   
Which Journals were investigated 
 
The American Journal of Orthodontics and Dentofacial Orthopedics, Angle Orthodontist, 
European Journal of Orthodontics and Journal of Orthodontics (Formerly British Journal of 
Orthodontics) were identified as key journals to search because Sun et al identified that of the 
large amounts of clinically relevant material available to orthodontists, 45% of the articles 
were published in five orthodontic journals.
100
 These were American Journal of Orthodontics 
and Dentofacial Orthopedics (formerly American Journal of Orthodontics), The Angle 
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Orthodontist, European Journal of Orthodontics, Journal of Orthodontics (formerly British 
Journal of Orthodontics) and International Journal of Adult Orthodontics and Orthognathic 
Surgery (ceased publication 2002).  The International Journal of Adult Orthodontics and 
Orthognathic Surgery ceased publication in 2002, so it was excluded from this investigation. 
The four remaining journals were also chosen because 71.45% of orthodontic RCTs 
published between 2003 and 2007 were in these journals.
101 
The American Journal of Orthodontics and Dentofacial Orthopedics (formerly American 
Journal of Orthodontics) is one of the oldest orthodontic journals having been first published 
in 1915. It is the journal of the American Association of Orthodontists, its constituent 
societies, the American Board of Orthodontics and the College of Diplomates of the 
American Board of Orthodontics. It aims to publish original peer-reviewed articles focusing 
on all phases of clinical orthodontic treatment. In 2010 it was the highest ranked orthodontic 
journal in terms of citations and impact factor. It is not surprising that it is the highest in 
terms of citations as it publishes many more articles than the other journals, as can be seen in 
Table 5.1.
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The Angle Orthodontist is the journal of the Edward H. Angle Society of Orthodontists. It is 
the only major orthodontic journal with a non-commercial, non-profit publisher -- The E. H. 
Angle Education and Research Foundation.  The journal states that it values this freedom 
from commercial interests which allows it to operate exclusively in the best interests of our 
readers and authors. It is completely free to access.
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The European Journal of Orthodontics states it “publishes scientific papers aimed at all 
orthodontists”, thus implying a focus on scientific as well as clinical research. It publishes 
research papers which “extend the scientific basis of orthodontics”.  The journal was first 
published in 1979, despite being the journal of the European Orthodontic Society it is happy 
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to publish articles from around the world but aims to provide a forum for orthodontists in 
Europe.
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The Journal of Orthodontics (formerly the British Journal of Orthodontics)   is the Journal of 
the British Orthodontic Society, despite this it has an international circulation and publishes 
articles from all over the world. It provides the most guidance on the scope and type of 
articles it aims to publish, namely “high quality, evidence-based, clinically orientated or 
clinically relevant original research papers that will underpin evidence based orthodontic 
care. It particularly welcomes reports on prospective research into different treatment 
methods and techniques but also systematic reviews, meta-analyses and studies which will 
stimulate interest in new developments.”108 
Journal Requirements for Publication 
 
 Levels of evidence of ethical research required prior to publication. 
American Journal of Orthodontics and Dentofacial Orthopedics 
 
The AJODO refers authors to the “Uniform Requirements for Manuscripts submitted to 
Biomedical Journals”.16 A conflict of interest statement must be provided with each 
submitted article. RCTs should be written up as per CONSORT Guidelines. However in its 
guidance to authors it states that Institutional Review Board approval must be obtained but 
makes no mention of informed consent. It advises that guest editorials, letters and review 
articles may be rejected if a conflict of interest exists.
102
   
The AJODO also makes use of the PERK (Publishing Ethics Resource Kit) resource,
103
 as us 
ed by all of Elsevier’s journals.  This is an online resource to support journal editors in 
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handling ethical issues in publishing, dealing with such matters as unethical behaviour by 
reviewers and misreporting of statistics.  
The AJODO is also a member of the Committee on Publication Ethics (COPE).
19
 COPE is a 
registered charity, concerned with the integrity of peer reviewed journals and includes many 
major publishing houses including Elsevier (AJODO) and Oxford University Press (EJO).  It 
provides a forum for academic editors to discuss issues related to the ethical integrity of work 
submitted to or published in their journals.  It also encourages members to seek investigation 
into possible episodes of research misconduct by applicants. 
Angle Orthodontist 
 
The guidelines for authors states that “if humans or animals were involved in the work” it 
requires “a statement that the rights of the human or animal subjects were protected and that 
approval was obtained from an identified institutional review board or  its equivalent.”104 On 
contacting the editor he clarified the AO’s editorial position by stating that the AO “reject 
manuscripts that demonstrate flagrant ethical abuse such as treatments that are not 
appropriate for the patient and any other procedure that is not in the patient’s best interest”. 
and “require authors to commit to any financial interests they may have with regard to their 
research.”105  
  
European Journal of Orthodontics 
 
The EJO is a member of COPE.  It draws authors’ attention to the Declaration of Helsinki, 
CONSORT statement on randomized controlled trials and the Guiding Principles in the Care 
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and Use of Laboratory Animals.
106
 This journal, like the JO, reserves the right not to accept 
papers unless adherence to the principles embodied in these documents is apparent.   
Ethical approval, where applicable, must have been obtained and details of such must be 
contained within the manuscript.
107
  
Journal of Orthodontics  
 
The guidance to authors of the JO states that all papers being submitted for consideration 
should contain a statement to the effect that the research has ethics committee approval and 
conforms to the Declaration of Helsinki.  A statement to this effect should be included in the 
submitted paper.
108
 The Editor reserves the right to request a copy of this letter from the 
relevant ethics committee or indeed a letter from the relevant ethics committee confirming 
that ethical approval was not required.  The guidance also draws the authors’ attention to the 
Guide for the Care and Use of Laboratory Animals.
106
  
Classification of Articles  
Articles were classified as RCTs, CCTs or not eligible using the Cochrane Collaboration 
Glossary.
109
 
Clinical Trial 
“An experiment to compare the effects of two or more healthcare intervention.  Clinical trial 
is an umbrella term for a variety of designs of healthcare trials, including uncontrolled trials, 
controlled trials and randomised controlled trials (also called Intervention Study). ”109 
Randomised controlled trial (RCT) 
 “An experiment in which two or more interventions, possibly including a control 
intervention or no intervention, are compared by being randomly allocated to participants.  In 
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most trials one intervention is assigned to each individual but sometimes assignment is to 
defined groups of individuals (for example in a household) or interventions are assigned 
within individuals (for example, in different orders or to different parts of the body).”109 
Controlled Clinical Trial (CCT) 
“Indexing term used in MEDLINE and CENTRAL.  Within CENTRAL it refers to trials 
using quasi-randomisation, or trials where double blinding was used but randomisation was 
not mentioned.”109 
 
 
 
 
 
 
 
 
 
 
 
51 
 
Chapter 3: Calibration and Reliability 
Studies 
Calibration Study  
Null Hypothesis 
There is no difference between RF’s identification of RCTs and CCTs and that of the 
Cochrane Oral Health Group Handsearching Test
110
 against the alternative hypothesis of a 
difference.  
Aim 
To calibrate RF in the detection of Randomised Controlled Trials (RCTs) and Controlled 
Clinical Trials (CCTs) as defined by the Cochrane Collaboration. 
Sample Frame 
Cochrane Collaboration Oral Health Group’s list of articles to assess as part of its 
handsearching test. 
Method 
The Cochrane Collaboration Oral Health Group handsearching test was undertaken in 
January 2010 prior to commencement of the handsearching for this study.  
Results 
RF passed the handsearching test. 
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Reliability Study  
Null Hypothesis 
There was no difference in the selection of papers fulfilling the criteria to be classified as 
either RCTs or CCTs by RF over time against an alternative hypothesis of a difference.  
Aim 
To determine the intra-examiner reliability of RF over time. 
 
Sample Frame 
Articles published in the American Journal of Orthodontics and Dentofacial Orthopedics 
(AJODO), Angle Orthodontist (AO), European Journal of Orthodontics (EJO) and Journal of 
Orthodontics (JO), (Formerly British Journal of Orthodontics) between 1
st
 January 2008 and 
31
st
 December 2008.   
Method   
All issues of the AJODO, AO, EJO and JO published between 1
st
 January 2008 and 31
st
 
December 2008 were handsearched to identify all articles reporting Randomised Controlled 
Trials (RCTs) and Controlled Clinical Trials (CCTs). This was performed in January 2010. 
These journals were recategorised again, after three months in April 2010, so as to allow the 
initial details to be forgotten. To prevent examiner fatigue only two journals were examined 
at any one time. The results were analysed for reliability. 
Intra-examiner agreement was assessed by tabulating the number of agreements and 
disagreements for each item, i.e. RCT or not and subsequently calculating a kappa score.  
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Inclusion Criteria 
Articles that fulfilled the Cochrane Collaboration Oral Health Group handsearching criteria 
for RCTs and CCTs were included in the study. These articles had to meet the following 
criteria: 
1. “The study compares healthcare treatment/interventions in human beings, 
2. The study is prospective in nature, i.e., the treatments/interventions are planned prior 
to the experiment taking place, and exposure to each intervention is under the control 
of the study investigators, 
3. Two or more treatments/interventions are compared to one another (or one may be a 
no treatment control group), 
4. The most important aspect is that assignment to a particular treatment/intervention is 
intended to be random, i.e., not deliberately selected in any way.  Units of 
randomisation may be individuals, groups (communities, schools, or hospitals), 
organs or other parts of the body (such as teeth). If the method of selection is quasi-
random or not stated, then we may give the study the benefit of the doubt and include 
it as a Controlled Clinical Trial (CCT)”.110 
Exclusion Criteria 
All articles which do not fulfil the above criteria. 
Statistical Methods 
Percentage agreement and Kappa statistic were used to determine reliability. 
Results   
The kappa score was 0.98 indicating excellent intra-examiner reliability.   
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Chapter 4: Main Study  
Aims 
This study aimed to: 
 Assess the number of Randomised Controlled Trials (RCTs) and Controlled Clinical 
Trials (CCTs) published in the American Journal of Orthodontics and Dentofacial 
Orthopedics (AJODO), Angle Orthodontist (AO), European Journal of Orthodontics 
(EJO) and Journal of Orthodontics (JO) (formerly British Journal of Orthodontics) 
between 2001 and 2010.  
 Determine the number of these trial reports which recorded having obtained ethical 
approval and informed consent. 
 Determine whether the omission of a statement referring to obtaining ethical approval 
and informed consent was an oversight of the authors or an omission of the trial 
process. 
 Determine the number of authors, number of centres, location, involvement of a 
statistician and the inclusion of random* in either the title or abstract or body of the 
RCTs. 
 Determine whether the factors above influence an RCT’s likelihood of having 
recorded that ethical approval and informed consent had been obtained. 
 Determine the sensitivity of identifying RCTs in the four journals under consideration 
using various electronic search methods, namely MEDLINE search via PubMed and 
Ovid for publication type RCT and PubMed free text search for random* AND 
orthodontic. 
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 Compare the electronic search methods with handsearching as the gold standard.  
Null Hypotheses 
1. Orthodontic randomised controlled trials and controlled clinical trials:  
      i. Do not have ethical approval from an institutional review board or equivalent.  
ii. Do not demonstrate that informed consent had been obtained from participants. 
2. The number of authors, number of centres, location, involvement of a statistician, year of 
publication and the inclusion of random* in either the title or abstract or body of the article 
were not predictive of an RCT having obtained ethical approval and informed consent. 
3. All orthodontic RCTs, published in the four journals, had random* in the title, abstract and 
body of the article. 
4. There was no difference between the sensitivity of electronic searching versus that of 
handsearching to identify orthodontic RCTs against an alternative hypothesis of a difference. 
Design 
A retrospective observational study.  
Sample Size 
Previous work identified that only 11% of papers reporting RCTs and CCTs in three major 
orthodontic journals published between 1989-98 demonstrated that both informed consent 
and ethical approval had been obtained.
4
 It is now a prerequisite for the publishing of an RCT 
or CCT that these criteria are included in the article, so one would expect the frequency of 
concordance with these criteria to be 100%.  To identify such a large change in compliance 
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would require a sample size of 2-4 papers per group.  Instead, the change in reporting rates 
over time was used to calculate the sample size. Harrison
4
 reported approximately a doubling 
of reporting incidence from 1989-93 to 1994-98.  A study reporting similar issues in oral and 
maxillofacial surgery also found approximately a doubling of papers with documented 
evidence of both ethical approval and informed consent having been obtained between 2005-
07. 
111
 Therefore a change in incidence of clinical trials having obtained both ethical approval 
and informed consent from 11% to 22% was investigated. This was used in Pocock’s formula 
(Fig 5.1)
112
 giving a total of 177 clinical trials. However when all of the journals were 
searched a total of 89 CCTs and 218 RCTs were found. It was decided to include all of these 
trials in the analysis. 
Fig 5.1. Pocock’s Formula       
 
Number per group= [p1(1-p1) + p2(1-p2)]     x   f(ab) 
                                                    (p2-p1)
2
 
 
p1 = proportion of RCTs in original research with ethical approval and informed consent 
p2 = proportion of expected RCTs in current research with ethical approval and informed 
consent 
f(ab) = factor (type I error (0.05), type II error (0.2)) 
 
Number per group= [0.11(1-0.11) + 0.22(1-0.22)]     x   7.9 
(0.22-0.11)
2
 
= [(0.11x0.89) + (0.22x0.78)]        x    7.9 
(0.11)
2
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= 22.46 x 7.9 
= 177.42 per group 
=354.84 
Method 
Sample Frame  
Articles were identified in: 
 American Journal of Orthodontics and Dentofacial Orthopedics (formerly American 
Journal of Orthodontics) (A) 
 The Angle Orthodontist (N) 
 European Journal of Orthodontics (E)  
 Journal of Orthodontics (formerly British Journal of Orthodontics) (J) 
These journals were chosen as Sun et al identified that 45% of orthodontic articles were 
published in five orthodontic journals,
100
 four being journals listed above and the fifth being 
the International Journal of Adult Orthodontics and Orthognathic Surgery  which ceased 
publication in 2002 which was therefore excluded. These four journals were also chosen 
because 71.45% of orthodontic RCTs published between 2003 and 2007 were published in 
these journals.
101
 In estimating the number of papers published in each journal, original 
research papers and case reports were included, whilst editorials, letters to the editor, erratum 
and commercial promotions were excluded.   
Identification of clinical trials 
All editions of the AJODO, AO, EJO and JO, published between January 2001 and 
December 2010, were handsearched to identify all papers reporting RCTs and CCTs. 
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Inclusion Criteria 
Articles fulfiling the Cochrane Collaboration Oral Health Group Handsearching definitions 
for either RCTs or CCTs.
110
 
Exclusion Criteria 
All articles which did not fulfil the above criteria. 
Included Articles 
Once identified, each article was assigned a reference code comprising of: 
 Journal single letter identifier e.g. (A, N, E, J), 
 Year of Publication, 
 Month of Publication 
 Sequential Number of that article from the journal’s content page, 
 For Example, N/2010/Jan/6 = Angle Orthodontist, 2010, January, Article 6. 
The total number of articles was calculated for both RCTs and CCTs.  A separate list was 
kept for both RCTs and CCTs. 
Assessment Criteria and Outcomes 
Each article, reporting an RCT or CCT was assessed for the following items: 
1. What type of trial was reported in the article, RCT or CCT. 
2. Inclusion of a statement that: 
i. Ethical approval had been obtained from a relevant ethics committee. 
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ii. Informed consent had been obtained from and freely given by 
participants.  
These outcomes were assessed as present or absent.  
Clarification of absent status for RCTs 
 In the RCTs, if both ethical approval and informed consent were absent, the first 
author was contacted directly for clarification of the paper’s status with respect to the 
above criteria.  
 If there was no response when attempts were made to contact the author or they were 
uncontactable then these papers were listed as not having obtained ethical approval or 
informed consent as these criteria were not mentioned in the article. 
The RCTs were further assessed as follows: 
1. The journal the article was published in: namely the AJODO, AO, EJO or JO. 
2. The number of authors: 1-3, 4-6 or >6. 
3. How many centres the RCT was performed in: 1, 2, >3. 
4. The location of origin of the RCT: EU (excluding the UK), UK, USA or Other. 
5. The involvement of a statistician: yes or no. 
6. The year of publication: between 2001 and 2005 inclusive or 2006 and 2010 
inclusive.  
7. Random* in the title: yes or no. 
8. Random* in the abstract, if not in the title: yes or no. 
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9. Random* in the body of the article, if not in the title or abstract: yes or no. (See 
Figure 5.2.) 
Figure 5.2. Location of Random* in paper. 
  
 
 
 
 
 
 
 
 
 
 
 
Random* in Title 
Yes No 
Random* in Abstract 
Yes No 
Random* in Body 
Yes No 
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Factors influencing data collection and analysis for the RCTs  
 
The impact of various factors on the likelihood of the RCT having obtained both ethical 
approval and informed consent or not was evaluated. The RCTs were divided into two 
groups, those which had both ethical approval and informed consent and those which did not. 
The “not” group had either ethical approval or informed consent or neither. This subdivision 
was performed on the advice of the statistician because more subdivisions would not have 
provided meaningful data as the numbers were too small, see Figure 5.3. It is recognised that 
this categorisation is descriptively important, as it implies that having either ethical approval 
or informed consent is to be regarded in the same light as obtainment of neither. 
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Fig 5.3. Subdivision of RCTs with ethical approval and informed consent or 
not.  
 
 
The authors of the RCTs which had neither ethical approval or informed consent were 
contacted as it was felt that the results could be potentially biased if the authors had actually 
obtained both ethics and consent but had inadvertently left out this fact. Therefore they would 
been recorded as not having obtained either but would it actual fact have obtained both. By 
contacting the authors it was hoped that the exact position of their article with regards to 
ethical approval and informed consent would be clarified, for example, whether they had 
definitely not obtained ethical approval and informed consent or whether they had omitted a 
No 
Ethical Approval √ 
Informed Consent x 
 
Ethical Approval x 
Informed Consent√ 
 
Ethical Approval x 
Informed Consent x 
 
Yes 
Ethical Approval √ 
Informed Consent√ 
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statement stating compliance with these criteria simply by accident. The authors were 
contacted via email using the email address provided on the article, each email was sent 
twice. A sample of an email and response can be seen in Appendix 2. However, despite these 
numerous attempts to contact authors, the response rate was extremely low with only two 
authors responding, a 3.4% response rate, therefore this was considered to be insignificant. 
Data Entry 
The data were entered into two customised Microsoft Excel spreadsheets (Microsoft Office 
2003, Microsoft Corporation, Redmond, WA98052-7329, USA). One customised for the 
CCT checklist and the other for the RCT checklist. The CCT checklist spreadsheet was made 
up of three columns for each criterion and a row for each CCT assessed. The spreadsheet for 
the RCT checklist comprised of sixteen columns representing the criteria being assessed and 
each row representing the RCT to be assessed. A maximum of three journals and the articles 
contained within were scored at any one time in order to prevent examiner fatigue and hence 
decrease scoring errors.  
Reliability 
To ensure that an acceptable level of intra-examiner reliability was being maintained for both 
assessment of the trials as RCTs or CCTs and the RCT and CCT checklists a reliability study 
was conducted during the main study.  
A list of ten per cent of the journal volumes were prepared by JEH using a random number 
generator,
113
 the articles in these journals were reclassified.  The RCTs and CCTs were 
reassessed by RF six months after the completion of the data collection for the entire sample. 
RF was blinded to the initial results whilst re-examining the articles. The reliability was 
assessed using the Kappa statistic and percentage agreement.   
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Statistical Methods 
Descriptive statistics were used to analyse baseline data.  Chi-squared test (χ2) was used to 
assess categorical data and risks ratio (RR) and 95% confidence intervals (95% CI) was used 
to assess binary data.  
A multilinear regression was applied to the RCT data to assess which factors were the most 
important in predicting compliance with ethical approval and informed consent.  
 The sensitivity of various methods of electronic searching was assessed.   
Statistical Analysis 
This was undertaken by using SPSS, version 19.
114
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Chapter 5: Results 
The results are subdivided into seven sections: 
5.1.General Characteristics 
5.2.RCTs 
5.3.CCTs 
5.4.Comparison of RCTs and CCTs 
5.5.Factors influencing ethical approval and informed consent in RCTs 
5.6.Identification of RCTs using various search methods. 
5.7.Results of calibration and reliability studies. 
 
5.1. General Characteristics  
All issues of the AJODO, AO, EJO and JO, published over the ten year period, were assessed 
for RCTs and CCTs. A total of 4784 articles were identified in 287 issues of the journals 
examined between 1
st
 January 2001 and 31
st
 December 2010 as seen in Table 5.1. A small 
number of these were RCTs and CCTs, 4.6% and 1.9% respectively. There were significant 
differences between the journals in the proportion of RCTs (χ2 55.5; degree of freedom (df) 
=3; p=0.001) and CCTs (χ2 8.12; df=3; p=0.044) that were published. The AO published the 
smallest percentage of RCTs at 2.8% and the AJODO published 36 CCTs, which comprised 
40.5% of all CCTs.
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Table 5.1 Overall number of journal issues and articles published 
Journal Number 
of issues 
Number 
of 
articles 
Percentage 
of articles  
Number 
of 
RCTs 
Percentage 
of all 
RCTs 
RCTs as a 
percentage 
of all 
articles 
published 
in the 
journal 
Number 
of 
CCTs 
Percentage 
of all 
CCTs 
CCTs as a 
percentage 
of all 
articles 
published 
in the 
journal 
AJODO 125 2242 46.9% 119 54.6% 5.3% 36 40.5% 1.6% 
AO 60 1341 28% 38 17.4% 2.8% 33 37.1% 2.5% 
EJO 61 879 18.4% 45 20.6% 5.1% 19 21.4% 2.2% 
JO 41 322 6.7% 16 7.3% 5% 1 1.1% 0.3% 
TOTAL 287 4784 100% 218 100% 4.6% 89 100% 1.9% 
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Number of journals and articles published  
The AJODO published the majority of articles (2242/4784=46.9%), while the fewest articles 
were published in the JO (322/4784=6.7%). As well as publishing more articles per journal 
the AJODO also published more issues each year, from 2006 it published a supplementary 
April issue also, further increasing the number of articles published. In comparison the AO 
and EJO publish bimonthly and the JO quarterly. The significant contribution of the AJODO 
can be visualised in Figure 5.1. 
Figure 5.1 Percentage contribution of each Journal to sample. 
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Number of RCTs and CCTs as a percentage of articles published 
RCTs and CCTs comprised a small number of all articles published over the ten year time 
period. RCTs made up 4.6% of all articles and CCTs 1.9% respectively, as seen in Table 5.2. 
 
Table 5.2 Number of RCTs and CCTs as a percentage of articles published.  
Clinical Trial Type Total  Percentage of total articles 
published (4784 articles) 
RCT 218 4.56% 
CCT 89 1.86% 
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5.2. RCTs 
Number of RCTs per journal 
A total of 218 RCTs were published in the four journals between 1
st
 January 2001 and 31
st
 
December 2010, comprising 4.6% of all articles published in the four journals, as seen in 
Table 5.3. 54.6% of these were published in the AJODO, RCTs comprised 5.3% of the 
articles published in the AJODO. This was a similar percentage for the EJO and JO at 5.1% 
and 5% respectively. The AO’s percentage of RCTs compared to the total number of articles 
was lower than the other journals at 2.8%. These differences were significant differences (χ2 
=55.5; df=3; p<0.001). 
 
Table 5.3 RCT numbers and journal of publication. 
Journal Number of RCTs Percentage of all 
RCTs 
RCTs as a 
percentage of all 
articles published 
in the journal 
AJODO 119 54.6% 5.3% 
AO 38 17.4% 2.8% 
EJO 45 20.6% 5.1% 
JO 16 7.3% 5% 
Overall 218 100% 4.6% 
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RCTs with ethical approval and informed consent 
Of the 218 RCTs published 106 had both ethical approval and informed consent, 59 had 
neither, 32 had obtained ethical approval only and 21 informed consent only. Thus 49% of 
RCTs were properly reported with ethical approval and informed consent, as can be observed 
in Table 5.4; Appendix 4, Figure 1. 
Table 5.4 Number of RCTs with ethical approval and informed consent 
 Number of RCTs Percentage 
Ethical Approval and 
Informed Consent 
              106               48.6% 
No Ethical Approval or 
Informed Consent 
               59                27.1% 
Ethical Approval only               32                14.7% 
Informed Consent only               21                  9.6% 
Overall             218                 100% 
 
  
 
 
 
 
 
 
 
 
 
71 
 
5.3. CCTs 
 
Number of CCTs per journal 
Between 2001 and 2010, 89 CCTs were published in the four journals examined, comprising 
1.9% of all articles published in the four journals. 
36 were published in the AJODO and 33 in the AO. The JO published one CCT only during 
this time period, so CCTs comprised 0.3% of all JO articles published in the ten year interval.  
As a percentage of total articles published the AO and EJO publish the greatest percentage of 
CCTs at 2.5% and 2.2% respectively. These differences were significantly different (χ2 =8.12; 
df=3; p=0.044). The distribution of these CCTs is seen in Table 5.5.  
Table 5.5 CCT numbers and journal of publication. 
Journal Number of CCTs Percentage of all 
CCTs 
CCTs as a 
percentage of all 
articles published 
in the journal 
AJODO 36 40.5% 1.6% 
AO 33 37.1% 2.5% 
EJO 19 21.3% 2.2% 
JO 1 1.1% 0.3% 
Overall 89 100% 1.9% 
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CCTs with ethical approval and informed consent 
Of the 89 CCTs published, 32 had both ethical approval and informed consent, 36 had 
neither, 8 had obtained ethical approval only and 13 informed consent only. Thus, only 36% 
of CCTs were properly reported with ethical approval and informed consent, as can be 
observed in Table 5.6; Appendix 4, Figure 2. 
Table 5.6. Number of CCTs with ethical approval and informed consent 
 Number of CCTs Percentage 
Ethical Approval and 
Informed Consent 
              32               36% 
No Ethical Approval or 
Informed Consent 
              36             40.4% 
Ethical Approval only                8                 9%  
Informed Consent only              13            14.6% 
Overall              89             100% 
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5.4. Comparison of CCTs and RCTs  
 
RCTs were generally better reported with regards to ethical issues than CCTs. 48.6% of 
RCTs had reported obtaining both ethical approval and informed consent whereas only 36% 
of CCTs had obtained same, as can be seen in Table 5.7; Apprendix 5, Figure 3. The number 
of CCTs which had obtained neither ethical approval or informed consent was higher for the 
CCTs at 40.4%, compared to the RCTs at 27.1%. These differences were significantly 
different (χ2 =8.9, df=3, p=0.031). 
Table 5.7. Number of RCTs and CCTs with ethical approval and informed 
consent 
 Number of 
RCTs 
Percentage of 
RCTs 
Number of 
CCTs 
Percentage 
of CCTs 
Ethical Approval 
and Informed 
Consent 
              106               48.6% 32 36% 
No Ethical 
Approval or 
Informed 
Consent 
               59                27.1% 36 40.4% 
Ethical Approval 
only 
              32                14.7% 8 9% 
Informed 
Consent only 
              21                  9.6% 13 14.6% 
Overall             218                 100% 89 100% 
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5.5. Factors influencing ethical approval and informed consent in 
RCTs  
 
A variety of trial characteristics were examined to investigate if any predicted the RCT 
having obtained ethical approval and informed consent. The factors investigated were; 
 Journal of Publication 
 Number of Authors  
 Number of Centres 
 Location of Origin  
 Involvement of a Statistician 
 Year of Publication 
 Random* in Title 
 Random* in the Abstract, if not the Title 
 Random* in the Article, If not the Title or Abstract. 
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Journal of Publication  
The journal has a statistically significantly (p=0.004) impact on the probability of the RCTs 
published in differing journals having ethics and informed consent.  
The overall average for papers having recorded both ethical approval and informed consent is 
48.6%, this belies a large range between the different journals with 75% of RCTs published 
in the JO having obtained both ethical approval and 26.3% of those published in the AO 
having obtained same, this can be visualised in Table 5.8; Appendix 4, Figure 4. 
Table 5.8. Journal of Publication and number of RCTs with ethical approval 
and informed consent. 
Journal  Ethics and consent 
 
Not ethics and  
consent 
AJODO 58 (48.7%) 61 (51.3%) 
AO 10 (26.3%) 28 (73.7%) 
EJO 26 (57.8%) 19 (42.2%) 
JO 12 (75.0%) 4 (25.0%) 
Overall 106 (48.6%) 59 (51.4%) 
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Number of authors 
The number of authors contributing to an RCT was very statistically significantly associated 
with the paper having obtained ethical approval and informed consent, p<0.001.  
As seen in Table 5.9; Appendix 4, Figure 5, 94.7% of RCTs, with greater than six authors, 
had ethical approval and informed consent compared to 45.5% of those with one to three 
authors. These differences were significant (χ2=17.8; df=2; p<0.001).  
Table 5.9. Number of Authors and number of RCTs with ethical approval and 
informed consent or not. 
Number of authors Ethics and Consent Not Ethics and Consent 
1-3 35 (45.5%) 42 (54.5%) 
4-6 53 (43.4%) 69 (56.6%) 
>6 18 (94.7%) 1 (5.3%) 
Overall 106 (48.6%) 112 (51.4%) 
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Number of centres  
The number of centres at which the trial was carried out was a significant factor in 
determining compliance with ethical approval and informed consent, with (χ2 =9.62; df=2; 
p=0.008).  Although the majority of the RCTs were performed at single centre sites, when 
they were performed in 2 or more sites they were much more likely to have obtained both 
ethical approval and informed consent, as can be seen in Table 5.10; Appendix 4, Figure 6. 
RCTs performed in one centre did not have ethical approval and informed consent in 56% of 
trials examined whereas those in three or more centres had ethical approval and informed 
consent in 71.4% of RCTs. 
 
Table 5.10. Number of Centres and number of RCTs with ethical approval and 
informed consent or not. 
Number of Centres Ethics and consent 
 
Not ethics and 
consent 
1 80 (44%) 102 (56%) 
2 16 (72.7%) 6 (27.3%) 
>3 10 (71.4%) 4 (28.6%) 
Overall 106 (48.6%) 112 (51.4%) 
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Location of Origin  
Location of origin was sub-divided into the following: 
1. EU (Excluding UK)  
2. UK 
3. USA 
4. Other 
Any RCTs from more than one country were classified according to the first author.The exact 
number of RCTs published by each country can be seen in Table 5.11; Appendix 4, Figure 7. 
All RCTs performed in the EU were carried out in countries which had obtained their EU 
membership status decades prior to the date of research publication.  It may thus be assumed 
that all research was therefore carried out under the auspices of EU legislation and guidance.  
Research from the EU countries had obtained ethical approval and informed consent for 55% 
of RCTs and not for 45%. 
Research from the UK was analysed separately.  This decision was made due to the 
disproportionately large number of RCTs published by authors from the UK and it was felt 
this merited its own individual assessment.  RCTs published by UK authors showed the 
highest level of compliance with obtaining both ethical approval and informed consent at 
65.2%, which along with the EU authors was the highest level, see Table 5.12. However, 
there was a low level of both ethical approval and informed consent obtained by RCTs 
performed in the USA at 29.3%. These differences were statistically significant (χ2 =15.7; 
df=3; p=0.001).  
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Table 5.11. Number of RCTs published by each country. 
Country of Publication Number of RCTs 
1. EU excluding UK  
Austria  1 
Belgium 1 
Denmark  1 
Finland  6 
Germany 7 
Greece  5 
Italy 9 
Netherlands 3 
Sweden 7 
2. UK 40 
3. USA 41 
4. Other  
Australia 10 
Brazil 19 
Canada 3 
China 3 
Egypt 1 
India 3 
Israel 3 
Japan 2 
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New Zealand 1 
Norway 2 
Peru  1 
Saudi 1 
Switzerland 1 
Thailand 1 
Turkey 20 
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Table 5.12. Location of Origin and number of RCTs with ethical approval and 
informed consent or not. 
Location of origin Total number of 
RCTs 
Percentage of Total 
RCTs 
Ethics and consent 
 
Not ethics and 
consent 
 
EU (Excluding UK) 40 
(18.4%) 
22 
(55%) 
18 
(45%) 
UK 66 
(30.3%) 
43 
(65.2%) 
23 
(38.4%) 
USA 41 
(18.8%) 
12 
(29.3%) 
29 
(70.7%) 
Other 71 
(32.6%) 
29 
(40.8%) 
42 
(59.2%) 
Overall 218 
(100%) 
106 
(48.6%) 
112 
(51.4%) 
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Involvement of a statistician 
The involvement of a statistician did not influence whether ethical approval and informed 
consent were reported, OR 1.13 (95% CI 0.63, 2.04).  
The assessment of whether a statistician was involved in the RCT was based on whether a 
statistician was one of the authors or thanked in the acknowledgements section. When the 
exact position of the author was unclear, for example if it was stated only that they worked in 
the “Orthodontic Department” their name and university was searched online via Google to 
investigate if they were a statistician. For those RCTs which stated that a statistician had been 
involved, ethical approval and informed consent were obtained in 50.8% of RCTs, whereas if 
a statistician was not involved, ethical approval and informed consent were obtained in 
47.8% of RCTs, as seen in Table 5.13; Appendix5, Figure 8.  
Table 5.13. Involvement of a statistician and percentage of RCTs with ethical 
approval and informed consent or not. 
Statistician Ethics and consent Not ethics and consent 
Yes 31 
(50.8%) 
30 
(49.2%) 
No 75 
(47.8%) 
82 
(52.2%) 
Overall 106 
(48.6%) 
112 
(51.4%) 
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Year of Publication 
The time period 1
st
 January 2001 to 31
st
 December 2010 was divided into papers published 
between 2001 and 2005 inclusive or 2006 and 2010 inclusive. These dates were chosen due 
to the instigation of the European Clinical Trials Directive in 2004. Of those RCTs published 
in 2005 or earlier 63.3% did not have ethical approval and informed consent compared with 
43% of RCTs published between 2006 and 2010. RCTs published in 2006 or later were 
significantly more likely to have ethical approval and informed consent, OR=2.29 (95% CI 
1.32, 3.99) than those published between 2001 and 2005, as seen in Table 5.14; Appendix 4, 
Figure 9.  
Table 5.14. Year of Publication and number of RCTs with ethical approval and 
informed consent or not. 
Year of Publication Ethics and consent Not ethics and consent 
2001-2005 33 
(36.7%) 
57 
(63.3%) 
2006-2010 73 
(57.0%) 
55 
(43.0%) 
Overall 106 
(48.6%) 
112 
(51.4%) 
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Random* in Title 
Of the 218 RCTs found, only 77, (35.5%) had random* in the title, see Figure 5.2. Of those 
RCTs with random* in the title, 66.2% had both ethical approval and informed consent, 
compared with 48.6% of RCTs that did not. If random* was in the title, this was significantly 
associated with the RCT having obtained both ethical approval and informed consent 
(OR=3.07, 95% CI 1.75, 5.48), see Table 5.15. 
Figure 5.2. Percentage of RCTs with random* in the title. 
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Table 5.15. Number of RCTs with random* in the title and ethical approval 
and informed consent or not. 
Random* in title Ethics and consent Not ethics and consent 
Yes 51 
(66.2%) 
26 
(33.8%) 
No 55 
(39.2%) 
86 
(61.0%) 
Overall 106 
(48.6%) 
112 
(51.4%) 
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Random* in Abstract but not Title 
Of the RCTs 167, (76.61%) had random in their abstract if not in the title, Figure 5.3. This 
was statistically associated (p<0.001) with the RCT having obtained ethical approval and 
informed consent. Of the RCTs that had random* in the abstract 92 (55.1%) had ethical 
approval and informed consent, whereas of those RCTs which did not have random* in the 
title or abstract, only 27.5% had ethical approval and informed consent, as seen in Table 5.16; 
Figure 5.14. This difference was statistically significant, (OR=3.24, 95% CI 1.63-6.44). 
Figure 5.3. Percentage of RCTs with random* in the abstract but not title. 
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Table 5.16. Number of RCTs with random* in the abstract but not title with 
ethical approval and informed consent or not. 
Random* in abstract but 
not title 
Ethics and consent Not ethics and consent 
Yes 92 
(55.1%) 
75 
(44.9%) 
No 14 
(27.5%) 
37 
(72.5%) 
Overall 106 
(48.6%) 
112 
(51.4%) 
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Random* in the main body of the paper and not the title or abstract 
Of the 44 RCTs (20.2%) of RCTs had only had Random* in the main body of the paper and 
not the title or abstract, see Figure 5.4, thus 96.8% of RCTs (211 RCTs) had random* 
somewhere in the article, either the title, or abstract or body, see Table 5.17. There were 
seven RCTs in which the word random* did not appear. Of these four had ethical approval 
and informed consent, while three did not. This difference was not statistically significant, 
(OR=0.70, 95% CI 0.15-3.21). 
Figure 5.4. Percentage of RCTs with random in the body of the article but not 
the title or abstract with ethical approval and informed consent or not. 
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Table 5.17. Number of RCTs with random in the title or abstract or body of 
the article with ethical approval and informed consent or not. 
Random* in title or 
abstract or body 
Ethics and consent Not ethics and consent 
Yes 102 
(48.3%) 
109 
(51.7%) 
No 4 
(57.1%) 
3 
(42.9%) 
Overall 106 
(48.6%) 
112 
(51.4%) 
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Logistical Regression 
A logistical regression analysis was used to determine the association of various predictors to 
the liklihood of RCTs having obtained ethical approval and informed consent. See Appendix 
3 for raw data. 
The predictors examined initially were: 
1. The journal the article was published in; namely the AJODO, AO, EJO or JO. 
2. The number of author; 1-3, 4-6 or >6. 
3. How many centres the RCT was performed in; 1, 2, >3. 
4. The location of origin of the RCT; EU (excluding the UK), UK, USA or Other. 
5. The involvement of a statistician; yes or no. 
6. The year of publication; either between 2001 and 2005 inclusive or 2006 and 2010 
inclusive.  
7. Random* in the title; yes or no 
8. Random* in the abstract, if not in the title; yes or no 
9. Random* in the body of the article, if not in the title or abstract; yes or no.  
Significant indictors of ethical approval and informed consent were the;  
 The journal of publication (p=0.004) 
 Number of authors (p<0.001) 
 Number of centres (p=0.008) 
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 Location of origin (p=0.001) 
 Year of publication (p=0.003) 
 Random* in Title (p<0.001) 
 Random* in Abstract not Title (p<0.001) 
Indicators which did not reach statistically significant levels were: 
 Involvement of a statistician (p=0.69) 
 Random* in Body of article (p=0.65) 
A logistic regression analysis showed the most significant indicators of ethical approval and 
informed consent to be: 
 Publication in the JO (p=0.018) 
 6 or more authors (p<0.001) 
 Random*  in the abstract not title (p=0.004) 
 Publication after 2004 (p=0.001). 
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5.6. Identification of RCTs 
Hand-searching identified 218 RCTs which fulfilled Cochrane criteria and which were 
published in the AJODO, AO, EJO and JO between 01/01/2001 and 31/12/2010. Ovid 
located 61 RCTs and was the least accurate, failing to locate 157. PubMed found 167 RCTs, 
it missed 51 (23.4%) of the total RCT number. When compared to the gold standard of hand-
searching, the free text search was the most sensitive, selecting 173 (79.4%), see Figure 5.15. 
However the specificity was low with 665 “RCTs” found. Ovid was significantly less 
sensitive than PubMed (OR 8.43, 95% CI 5.48, 12.97) missing 157 RCTs (72.0%), while 
PubMed missed 51 (23.4%) see Figure 5.16.  The free text PubMed search, using the terms 
orthodontic AND random*, was the most sensitive missing 45 RCTs (20.6%) but this was not 
statistically significant (OR 0.85, 95%CI 0.54, 1.34) when compared with PubMed.  
A combination of all three electronic search methods underestimated the number of RCTs 
compared to handsearching by 17%. 56 RCTs (25.7%) were found by all three electronic 
search methods, see Table 5.18; Figure 5.5. 
Table 5.18. Number of RCTs found and missed by all search methods 
Search Method Found Missed 
Ovid 61 157 
PubMed 167 51 
Free Text 173 45 
Handsearching 218 0 
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Figure 5.5. Number of RCTs found and missed by all three electronic search 
methods. 
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Chapter 6. Discussion. 
The total number of RCTs and CCTs published in the AJODO, AO, EJO and JO from 1
st
 
January 2001 to 31
st
 December 2010 was 218 and 89 respectively. This comprised a very 
small percentage of all articles published over the time period, with RCTs making up 4.6% of 
all articles published and CCTs contributing 1.9%. 
 CCTs 
77.5% of all CCTs were published in the AJODO and AO combined with the JO publishing 
just one CCT over the ten year period. There was a low level of compliance with the 
Declaration of Helsinki, with 36% had both ethical approval and informed consent and 39.3% 
having neither. Ethical approval only was obtained by 8.7% of CCTs and informed consent 
only by 14.6%. 
RCTs 
There were 218 RCTs published. This was significantly more than the number of CCTs 
published (OR 2.5). 54.6% of all RCTs were published in the AJODO. Possible reasons for 
this are discussed later. The EJO published 20.6% of the RCTs, the AO 17.4% and the JO 
7.3%. However, as a percentage of total number of articles published, the AJODO, EJO and 
JO all published approximately the same percentage of RCTs. 5.3% of AJODO articles, 5.1% 
of EJO articles and 5% of JO articles were RCTs. The AO published the lowest percentage of 
RCTs at 2.8%. 
Compliance with the ethical approval and informed consent components of the Declaration of 
Helsinki was better with RCTs than CCTs although it was still well below the expected 100% 
compliance, as all trial reports involving human participants should include a statement 
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stating compliance with the Declaration of Helsinki. Of the 218 RCTs, 106 (48.6%) had both 
ethical approval and informed consent and 59 (27.1%) had neither. Ethical approval only was 
obtained by 32 (14.7%) of RCTs and informed consent only by 21 (9.6%). The authors of 
those RCTs which did not mention obtainment of either ethical approval or informed consent 
were contacted. Many of the email addresses provided in the article were not functioning. 
There was a very low response rate with only two authors responding (3.4%) and thus this 
was not investigated further. The RCTs were investigated with regards to various trial 
characteristics, along with whether these were associated with an increased likelihood of 
obtaining ethical approval and informed consent. These included the;  
 Journal of publication 
 Number of authors  
 Number of centres the RCT was performed in 
 Location of origin of the RCT  
 Involvement of a statistician 
 Year of publication 
 Random* in the title 
 Random* in the abstract, if not in the title 
 Random* in the body of the article, if not in the title or abstract.  
These trial characteristics were chosen once all the RCTs had been selected as these were 
characteristics which varied significantly between RCT reports. Other characteristics 
which could have been investigated may have included funding or journal impact factor.  
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Journal of publication 
The journal in which the RCT was published had a significant impact on the likelihood of an 
RCT having obtained both ethical approval and informed consent, p=0.004. 12 of the 16 
(75%) RCTs published on the JO had obtained both ethical approval and informed consent. 
The AO was the least compliant with only 10 (26.3%) of RCTs having obtained both. The 
AJODO, AO and EJO were broadly similar in the number of RCTs which had obtained 
neither ethical approval nor informed consent, this percentage ranged from 22.2% for the 
EJO to 36.8% for the AO. The overall average for RCTs having recorded both ethical 
approval and informed consent was 48.6%, but this belies a large range between different 
journals. Thus the journal had a statistically significant impact (p=0.004) on the probability of 
the RCTs published in different journals having obtained ethical approval and informed 
consent.  
A significantly greater number of articles were published in the AJODO.  This can be 
explained by a number of factors, including that fact that it publishes editions 12-13 times per 
year, in addition having a number of papers available online only. Its mean number of papers 
per issue is less than that of the AO at 18 for the AJODO versus the AO’s 22. Despite this 
increased number of articles its percentage of RCTs was broadly similar to the EJO and JO 
and higher than the AO. 
Why compliance was greater in the JO was not examined, however this may be due to the 
editorial policy, early adoption of the CONSORT Guidelines and a tighter refereeing process.  
Number of authors  
The number of authors was very statistically significantly associated (p<0.001) with the RCT 
having obtained both ethical approval and informed consent. Only 45.5% of RCTs with 1 to 3 
authors had ethical approval and informed consent whereas 94.7% of RCTs with >6 authors 
fulfilled these criteria. This is perhaps due to the hypothesis that as more people are involved 
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it is more likely that at least one of the authors will consider it an important criteria to have 
fulfilled. This may perhaps be due to the trials with increasing numbers of authors being more 
likely to be multi-centre trials. Those funded by a government department or agency, for 
example the Medical Research Council in the UK, would insist on appropriate procedures 
being followed, especially with regards to the protection of the participants. 
Number of centres the RCT was performed in 
The number of centres the RCT was carried out in was also significant (p=0.008). Although 
the majority of RCTs were performed at single site centres (182), when RCTs were 
performed in 2 or more sites, they were much more likely to have obtained ethical approval 
and informed consent, 44% versus >88%. This may be explained by multicentre trials being 
larger and more likely to be in receipt of funding from external sources and thus the 
methodology is more closely supervised and associated with tighter processes.  
Location of origin of the RCT  
The location an RCT was based in had a significant impact on whether ethical approval and 
informed consent had been obtained (p=0.008). Research from the UK was analysed 
separately to that from the rest of the EU. This decision was made due to the 
disproportionately large volume of RCTs published by authors from the UK and it was felt 
this merited its own individual assessment. RCTs published by UK authors showed the 
highest level of compliance with the Declaration of Helsinki, namely that they have obtained 
both ethical approval and informed consent. RCTs published by UK authors had obtained 
both ethics and consent in 65.2% of cases, which along with the EU authors was the highest 
level.   
There was a low level of both ethical approval and informed consent having been obtained by 
RCTs performed in the USA (29.3%). This may be due to a large number of American trials 
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being published in the AO which has a low level of compliance with ethical approval and 
informed consent. Another interesting feature, which was apparent on review of the literature, 
was that trials performed in the USA in particular are reported multiple times.
115,116,117, 118 It is 
generally, but not always, different aspects of these trials that were reported.  This tendency 
to publish many articles from the same piece of research, or “salami slice” may be due in part 
to the need in academia to “publish or perish” and to ensure that funding authorities, 
universities or other stake holders in the research get the maximum amount of publications in 
ideally high impact journals. 
Involvement of a statistician 
The involvement of a statistician was not statistically significantly associated (p=0.86) with 
an RCT having both ethical approval and informed consent. When the exact position of the 
author was unclear, for example if it was stated only that they worked in the “Orthodontic 
Department” their name and university was searched online via Google to investigate if they 
were a statistician. This method is likely to underestimate the involvement of statisticians in 
this group of RCTs as not all the statisticians involved in the RCT are likely to either be an 
author or acknowledged.  It is generally held that all people who make a meaningful 
contribution to the research should be listed as an author. This may make the process more 
transparent and in the case of the statistician, acknowledge the important role they play. Some 
journals, such as the JO, request that each author or contributor state their contribution to the 
research. This method could be adopted by all journals to ensure the involvement of a 
statistician and that each individual’s role is acknowledged and recognised. Accurate 
statistical reporting and the use of appropriate statistical analyses, are becoming more crucial 
in the peer review process, with some journals involving statisticians as peer reviewers.   
99 
 
Year of publication 
The year of publication was statistically significantly (p=0.002) associated with a paper 
having acquired ethical approval and informed consent. The time of publication was divided 
into two groups, 2001 to 2005 and 2006 to 2010. These dates were chosen as they divided the 
ten year time period into two and also because the European Clinical Trials Directive (ECTD) 
was published in 2004.This highlighted the importance of the academic communities’ 
attention once more to the need for ethical approval and informed consent and standardised 
the procedure throughout the EU. The significance of these results suggests that the 
implementation of the ECDT had a positive effect on the conduct of trials. The differences 
between EU trials and the rest of the world could be investigated further. 
Random* 
When handsearching the journals for RCTs it became apparent that contrary to the 
CONSORT Statement,
119
 RCTs were not being published with “Randomised Controlled 
Trial” in the title. Thus each RCT was assessed as to whether it contained random* in the 
title, or the abstract if not the title, or body of the article if not the title or abstract. Random* 
was chosen to account for any differences in the spelling of randomised, for example 
randomized. 
Random* in the title 
Of the 218 RCTs found, only 77 (35.5%) had random* in the title. This has a significant 
impact on the selection of RCTs for systematic reviews via electronic search methods.  If 
random* was in the title, this was strongly associated with the RCT having obtained both 
ethical approval and informed consent with p<0.001.  
Although random* in the title or as a keyword is one of the CONSORT Guidelines, as is a 
statement confirming ethical approval and informed consent have been obtained. However 
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these guidelines do not appear to be widely followed in the reporting of orthodontic RCTs. 
Therefore perhaps those RCTs which have random* in the title are more likely to be written 
up as per CONSORT Guidelines and have recorded obtaining ethical approval and informed 
consent. 
Random* in the abstract, if not in the title 
 
167 (76.61%) RCTs had random in their abstract if not in the title. This was statistically 
associated (p<0.001) with the RCT having obtained ethical approval and informed consent. 
Of the RCTs which did not have random* in the title or abstract 72.5% did not have ethical 
approval and informed consent.  
Stating the paper is an RCT, either directly in the title or by indirectly implying it, for 
example, by discussing the randomisation process is a feature that one whould expect most 
RCTs to adhere to. Those RCTs which do not contain this are perhaps poorly reported and 
may thus either not have obtained, or else fail to mention having obtained ethical approval 
and informed consent. 
Random* in the body of the article, if not in the title or abstract.  
Of the 218 RCTs, 44 (20.2%) had only Random* in the main body of the paper and not the 
title or abstract, thus 96.8% of RCTs (211 RCTs) had random* somewhere in the article, 
either the title, or abstract or body. There were 7 RCTs in which the word random* did not 
appear;. Of these 4 had ethical approval and informed consent and 3 did not. The likelihood 
of these RCTs being selected for a systematic review is extremely low as they require reading 
of the entire article and then clarification of the methodology in a separate article. This will 
significantly reduce their likelihood of being selected electronically for inclusion in, for 
example, a systematic review. If all RCTs on a particular topic are not included then there is a 
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risk of bias in that systematic review and thus in treatment effect being over or 
underestimated. 
Significant indicators of ethical approval and informed consent 
A logistic regression analysis (see Appendix 3) showed the most significant indicators of 
ethical approval and informed consent to be: 
 Publication in the JO (p=0.018) 
 6 or more authors (p<0.001) 
 Random*  in the abstract not title (p=0.004) 
 Publication after 2006 (p=0.001) 
This showed that although the numbers of RCTs which were published in the JO or had 6 or 
more authors were small they were well reported ethically.  
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Identification of RCTs 
 
When handsearching the journals for RCTs and CCTs it became apparent that contrary to the 
CONSORT Statement RCTs were not being published with “Randomised Controlled Trial” 
in the title. Thus each RCT was examined under the following criteria: whether it had 
RANDOM* in the title, abstract or main body of the paper.  
These finding led to the hypothesis that due to lack of accurate labelling of RCTs electronic 
search engines, i.e. Ovid and PubMed would underestimate the number of RCTs on a topic, 
which would therefore bias the results of a systematic review in the subject. 
Systematic reviews aim to select and appraise all high quality research relevant to a particular 
question. They are specifically designed to minimise bias, so as to produce the most reliable 
findings to most accurately inform decision making.  Such reviews generally only include 
RCTs. If the systematic review fails to include all relevant RCTs, bias in estimating treatment 
effect will arise. It must be considered that systematic reviews are increasingly used for a 
variety of purposes,
120
 such as by a grant agency to ensure that there is sufficient need for 
research in that particular area, by clinicians to keep up to date with their speciality, by 
journals to assess the merit in publishing research in an area
 122
 and, increasingly, in the 
development of clinical guidelines.
123, 124
 For these aims to be achieved to a satisfactory 
degree, it is essential that systematic reviews accurately represent the body of research 
available for that particular subject.  
This research demonstrates that the number of orthodontic RCTs in the literature is 
significantly underestimated by using electronic searching alone, either via free text searches 
or by publication type. Electronic searching is the main medium for trial selection for many 
systematic reviews including Cochrane.
6
 It is likely that this underestimation of RCT 
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numbers is not confined to orthodontics or indeed dentistry as a whole. To improve the 
specificity of electronic searches journal editors should ensure that one of the keywords for 
RCTs is random and that, as per CONSORT Guidelines, RCTs are clearly identified in the 
title as such.  
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What do the findings mean? 
Many reports of RCTs and CCTs do not comply with ethical guidelines. Each of the journals’ 
guidelines to authors noted that a statement which confirms compliance with both ethical 
approval and informed consent should be contained within each submitted manuscript. This 
may be the case, however, these statements are not being published. This has implications for 
journals’ referees and editors as it is they who have the final say on the wording of published 
articles and thus must ensure that such a statement is included in the finished manuscript. 
Also they must ensure that the editorial and reviewing process will not allow any research on 
human participants and more broadly on animals to be published if it has not reached the 
minimum ethical standards. Furthermore it important that any RCTs are correctly labeled as 
such and categorised accurately in online databases such as MEDLINE. This may be 
improved by providing a checklist for referees, this may help ensure that papers are 
rigourously assessed and subsequently categorized correctly. 
Due to lack of compliance with the CONSORT Statement on reporting of RCTs, it is difficult 
to locate RCTs effectively and with acceptable specificity and sensitivity using electronic 
search methods. Handsearching was much more effective, however it is extremely time 
consuming and not regularly performed. However once handsearching has been done it does 
not need to be repeated if kept on a contemporaneous database. Thus, most searches for 
RCTs, for example for use in systematic reviews, compiling guidelines and arranging grant 
applications, are more likely to be performed by electronic searching. It is of concern that this 
research demonstrates an underestimation of RCT numbers by 17%, even when combining 
three different electronic search methods, as this could lead to significant bias in the 
aforementioned use of RCTs.  
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Although 218 RCTs are reported here, the actual number of RCTs is lower as many of these 
RCTs are the same trial reported more than once. Even when comparing the 218 RCTs to the 
total of 4847 published articles, this is extremely low and results in the evidence basis for 
orthodontics being less robust than ideal. It highlights the need for future RCTs in 
orthodontics and the importance of the correct categorization of these trials so their value in 
developing a strong evidence base for orthodontics can be maximized. 
Multiple reporting of RCTs is particularly apparent in RCTs based in the USA, as discussed 
previously. This may be one of the reasons why journals such as the AJODO report more 
RCTs, though part of this is likely to be the AJODO’s impact factor. Unfortunately, the JO 
does not have an impact factor, which may lead UK researchers to preferentially publish in 
the AJODO, AO or EJO rather than the JO. 
Comparison with other studies 
 
A review of five major medical journals, namely the BMJ, (International Edition), The 
Lancet (British Edition), Annals of Internal Medicine (Annals), the Journal of the American 
Medical Association (JAMA) and the New England Journal of Medicine (NEJM) which 
assessed all clinical research articles from 1
st
 January 2005 to 31
st
 December 2006 under the 
criteria of having obtained ethical approval and informed consent.
125
 The results of this 
research was much more positive than that published in Orthodontics and Oral and 
Maxillofacial Surgery with only 3.2% of published clinical research not having recorded 
ethical approval, 5.5% not having recorded informed consent and 1.3%  not having recorded 
either, as seen in Table 6.1. The variations seen over time and between different journals, as 
seen in the reporting of Orthodontic Clinical Trials, was also noted in this study.
125
 Although 
this study looked only at a two year period, there was a statistically significant difference in 
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the incidence of failure to report ethical approval between 2005 and 2006 (p=0.005), the 
difference in failure to obtain consent between the two years was not significant (p=0.510).   
There were also statistically significant differences between the quality of ethical reporting 
between journals. RCTs were the best reported of the different research types and were least 
likely to be missing statements stating that ethical approval (p=0.001) and informed consent 
(0.005) had been obtained.   
These journals had been investigated previously by Schroter.
126
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Table 6.1. Comparison of ethical approval and informed consent in different 
specialities. 
Speciality Incidence of 
reporting of 
ethical approval 
(number of 
articles) 
Incidence of 
reporting of 
informed 
consent 
(number of 
articles) 
Time period Research 
type 
Orthodontics 63.0% (138) 58.3%(127) 2001-2010 RCTs 
CCTs 
Oral and 
Maxillofacial 
Surgery
111
 
22.0% (118) 25.0% (135) 2005-2007 “All 
research 
involving 
human 
subjects” 
General 
Medicine
125
 
96.8% (1097) 94.5% (1071) 01/01/2005-
31/12-2006 
“All clinical 
research 
articles” 
Anaesthetics
127
 71% (845) 66% (726) 2001 “All 
publications 
involving 
human 
participants” 
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Comparison with previous orthodontic research 
Harrison’s research4 investigated the incidence of ethical approval and informed consent for 
RCTs and CCTs published between 1989 and 1998. 70 CCTs and 85 RCTs were published 
over the time period. She found that of the RCTs 17% had ethical approval and 34% stated 
informed consent had been obtained. Of the CCTs published 16% mentioned obtainment of 
ethical approval and 14% obtained informed consent. In total 11% of trial reports mentioned 
both ethics and consent. No statistically significant difference over time in the incidence of 
obtainment of ethical approval and informed consent was noted. 
 There were significant differences between the CCTs and RCTs published between 1989 to 
1988 and 2001 to 2010.  
The number of RCTs increased sharply from 85 to 218. There was a large improvement in 
the number of RCTs with ethical approval and informed consent from 17% to 63.3% and 
34% to 58.3% respectively. 
 Of the CCTs, there was a similar number published over both time periods, with 85 between 
1989 to 1998 and 89 between 2001 to 2010. Considering the large increase in RCT numbers 
the fact that there was not a corresponding increase in CCT numbers was surprising. This 
may perhaps be due to the strict criteria a CCT must fulfill to be classified as such by 
Cochrane. There was a large improvement in both ethical approval and informed consent 
over the time period, from 16% to 45% and 14% to 50.6% respectively. 
Overall the number of trials with both ethical approval and informed consent increased 
from11% to 45%. 
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Within the 10 year period 2001-2010 there was a statistically significant difference in the 
number of RCTs with ethical approval and informed consent published between 2001 to 2005 
and 2006-2010. Those RCTs published in 2006 or later were better reported ethically with 
57% having ethics and consent compared to 36.7% of those published between 2001 to 2005 
(OR=2.29, 95% CI 1.32, 3.99).    
The improvements in reporting of ethical approval and informed consent fits in with the other 
available literature showing that reporting of these important criteria is improving over time. 
Generalisability 
The results of this study are probably only applicable to orthodontics in terms of the 
compliance of RCTs and CCTs with ethical approval and informed consent. This is because 
there appears to be a large amount of variation in compliance with ethical approval and 
informed consent between various specialities, as seen in Table 6.1. Despite this the 
CONSORT Statement is an evidence-based minimum set of recommendations for reporting 
RCTs, thus all RCTs should be reported according to it across all dental and medical 
specialities, therefore for full compliance all RCTs across all specialities would have 
confirmation of obtainment of ethical approval and informed consent. 
The Cochrane Handsearching course is also applicable to all healthcare trials and its findings 
derived from handsearching following this protocol are also generalisable. The finding that 
electronic searching is less sensitive at locating RCTs than handsearching is likely to be 
generalisable across different specialities and has been previously proven in other spheres of 
medicine, see Table 6.2. 
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Table 6.2. Comparison of electronic searching versus handsearching in other 
medical specialities. 
Comparison Subject Result 
Electronic searching V 
Handsearching 
Cochrane
133
 Handsearching 92-100%  
MEDLINE 55%,  
EMBASE 49% and  
PyscINFO 67%. 
 
MEDLINE V 
Handsearching 
 
Mental Health Care
134
 MEDLINE 52% (CI 48-56%) 
Handsearching 94% (CI 93-
95%) 
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Limitations of the study 
Handsearching  
The handsearching method followed was that of the Cochrane Collaboration. This was 
originally instigated to form the Cochrane CENTRAL Register of Controlled Trials which is 
the Cochrane Collaboration’s source of trial reports. This lays down strict criteria for the 
classification of RCTs and CCTs. Due to the strictness of these criteria and the inherent risk 
of missing trials due to inaccurate searching, there is a risk that the number of trials included 
may be incorrect and therefore produce biased results. This was assessed by a pilot study and 
checking intra-examiner reliability which was high. Although there are risks of introducing 
biases with handsearching it was found to be a far superior method of RCT selection 
compared to various methods of electronic searching. 
Handsearching depended on information provided by authors. In some RCTs, ethical 
approval and informed consent were not mentioned by the author. The authors of these RCTs 
were contacted as it was felt that the results could be potentially biased if the authors had 
actually obtained both ethics and consent but had inadvertently left out this fact. However, 
despite numerous attempts to contact authors, the response rate was extremely low (3.6%) 
and therefore this was considered to be probably insignificant. Many of the email addresses 
provided in the article were not functioning, even those provided recently, and perhaps it is 
an important role of the journal to ensure that authors are contactable with accurate 
functioning contact details. Perhaps it would be better to have the contact details of the 
supervising author who are perhaps likely to be in the Department for a longer period of time, 
rather than, for example a Specialist Registrar. There is little evidence on whether such 
papers are likely to have ethical approval and informed consent or not, it has been 
investigated by Perkins in dermatology.
128
 This paper contacted all authors who submitted 
112 
 
their research on human participants for publication in the Journal of the American Academy 
of Dermatology (JAAD) and had failed to mention ethical approval or informed consent. Out 
of the original 150 submitted studies, 36% (n=54) did not mention ethical approval in the first 
instance. 15% (n=22) mentioned consent but not ethics. The authors of 42 of these papers 
which did not mention ethics were contacted by editorial staff, the remaining papers were not 
considered suitable for inclusion in the journal, thus potentially biasing the outcome of this 
particular study.  Of those 42 papers which were being considered, the authors were then 
contacted for clarification of the ethical status of their research. 20 (48%) of the papers were 
returned with the required information and 3 papers confirmed their exemption from the 
ethical approval process. However the remaining papers were either withdrawn (n=9), not 
resubmitted (n=5) or acknowledged to be lacking in ethical review (n=5). When contacted by 
editorial staff there was a relatively good response rate, however this may be subject to bias 
due to the high proportion of papers which were not considered suitable for inclusion in the 
journal whose authors were not contacted and the high number of papers which were then 
withdrawn, or not resubmitted, when clarification on their ethical status was sought. A 
percentage of these papers may not have had ethical approval but it is unfortunately not 
possible to tell what percentage. The difference in response rate may be due to the fact that 
the authors of the orthodontic papers had already had their research published whereas those 
prospective dermatology authors had to reply to the journal editor to have their research 
considered for publication.  
Identification of Papers 
This was a retrospective study which, by its nature, was open to bias.  All papers published 
within the four main orthodontic journals over the ten year period were handsearched to 
identify RCTs and CCTs. It is possible mistakes were made due to human error and articles 
which should have been included in the sample were omitted. This is made more likely due to 
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the poor titling of the RCTs which makes them more difficult to identify. Conversely, some 
studies which were neither a RCT nor CCT may have inadvertently been included. All 
precautions possible were taken to avoid this, this was checked by researching a random 
sample of 10% of the journals which demonstrated good intra-examiner reliability. 
As electronic searching was carried out by three different methods it was thought that this 
would also aid in assessing handsearching reliability as it may have located additional RCTs 
which were missed by handsearching. However, no additional RCTs were found.  
Sample size  
The original sample size was based on Harrison’s work4 and a similar article published in 
Oral and Maxillofacial surgery
111
 both of which showed an approximate doubling in the 
incidence of reported ethical approval and informed consent over the time period examined. 
The necessary sample size at 90% power would have been 177 trials. Instead it was decided 
to include all RCTs and CCTs which were found during handsearching, thus by including all 
relevant trials it was hoped that this would reduce bias. 
Quality 
During the data collection process, no attempts were made to assess the quality of the 
individual trials, for example, how the RCTs were randomised or blinded. It was thought to 
be outside the remit of this study to assess this, this will ideally be analysed at a later date. 
Previous research in this area has shown that these criteria are inadequately reported.
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Previous work assessing the quality of published RCTs by the Cochrane Collaboration has 
identified a lack of methodological rigour or clarity in some RCTs which has resulted in their 
exclusion from systematic reviews.
129
 A paper by Tuech et al assessed and compared the 
methodological quality and ethical quality of all Stage III cancer RCTs published in ten 
journals over a three year period.
130
 This paper found an association between methodological 
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and ethical quality, perhaps showing closer attention to all aspects of the research process. 
This was also seen in the orthodontic research examined where larger trials with more authors 
and centres appeared to comply better with ethical guidelines, possibly as these trials are 
planned and performed to a higher standard. Compliance with the CONSORT Statement is 
considered to be indicative of a high quality, well reported RCT. For RCTs to be written up 
in such a format it is important that journals engage with this Statement and request that 
RCTs are written up in such a format. This is not the case yet with 38% (n=62/165) of high 
impact medical journals mentioning the CONSORT Statement in their “Instructions to 
Authors”, of these 62, 37% (n=23/62) stated in was a requirement and the remaining 63% 
(n=39/62) were less clear.
131
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Implications for Practice 
Clinical 
The main implication for practice is that this research indicates that electronic searching 
significantly underestimates the number of RCTs located. Even by combining three electronic 
search methods, 17% of RCTs were not located. Thus systematic reviews, based on this 
cohort of RCTs, may be subject to treatment effect bias and what we consider to be the best 
evidence, namely the systematic review, may be significantly biased. 
Research 
This research shows the importance of accurately labelling and classifying RCTs, both by 
including “randomised controlled trial” in their title, as per CONSORT Guidelines, so that 
they can be located during electronic searching and ensuring they are accurately classified in 
MEDLINE to ensure they can be located by PubMed or Ovid.  
With respect to trials having reported ethical approval and informed consent, it is important 
that the editors ensure that these trials have obtained these ethical criteria and a statement 
conforming this is within the article.  
In light of the difficulty contacting the authors of those RCTs without ethical approval and 
informed consent perhaps there should be a requirement to inform the journal of any changes 
to contact details and to ensure that they are functioning in the first place. Or perhaps the 
contact author should be the most senior author as they are likely to be the most stable person 
and remain working in the same department for the longest period of time, rather than, for 
example, a Specialist Registrar. 
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Further Research 
 It has been shown in medicine that all RCTs are not included in systematic reviews,132 
and that this may bias the results of the systematic reviews. It would be interesting to 
take a selection of systematic reviews and assess whether they had included all 
relevant RCTs and compare these to Cochrane systematic reviews which also include 
handsearching. 
 On searching the orthodontic literature much “salami-slicing” was apparent, with 
some extremely similar articles being published by the same research team. This was 
also obvious in the reporting of RCTs with the results of some RCTs and CCTs being 
sliced up and published in a number of papers. It appeared that there was a geographic 
divide in this regard. This would be worth investigating further, along with the 
multiple reporting of laboratory based research. 
 Lack of recorded registration of animal trials also appears widespread in the 
orthodontic literature and could be researched in a similar way. 
 This research should be repeated in approximately another decade to assess whether 
the rate of reporting of ethical approval and informed consent continues to improve. 
 Assessment of the quality of RCTs published within these four main orthodontic 
journals in relation to CONSORT Guidelines.  
 
 
 
 
117 
 
Chapter 7: Conclusions 
 There were 218 RCTs and 89 CCTs published in the AJODO, AO, EJO and JO 
between 2001 and 2010. 
 Of the 89 CCTs reported, 32 (36%) had both ethical approval and informed consent, 
36 (40.4%) had neither and 21 (23.6%) had either ethical approval or informed 
consent. Of the 218 RCTs reported, 106 (48.6%) had both ethical approval and 
informed consent, 59 (27.1%) had neither and 53 (24.1%) had either ethical approval 
or informed consent. 
 Attempts were made to contact the authors whose RCTs did not mention either ethical 
approval or informed consent. However there was a very low response rate of two 
authors, (4.6%), so this was considered insignificant.  
 Significant indicators of an RCT having obtained both ethical approval and informed 
consent were; the number of authors, random* in the title, random* in the abstract not 
title, location of origin, year of publication, journal of publication and number of 
centres. Of these publication in the JO, 6 or more authors, random* in the abstract not 
title and publication after 2006 were the most significant.  
 Handsearching was more sensitive in the selection of RCTs than electronic searching. 
When combining three methods of electronic searching, namely MEDLINE via Ovid, 
publication type “RCT”, MEDLINE via PubMed, publication type “RCT” and 
PubMed Free Text search for “orthodontic” AND “random*” 38 (17%) of RCTs were 
not found by any of the three electronic search methods. 
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Appendix 1. Cochrane Collaboration 
Glossary Definitions. 
Clinical Trial 
“An experiment to compare the effects of two or more healthcare intervention.  Clinical trial 
is an umbrella term for a variety of designs of healthcare trials, including uncontrolled trials, 
controlled trials and randomised controlled trials (also called Intervention Study). ”109 
Controlled Clinical Trial (CCT) 
“Indexing term used in MEDLINE and CENTRAL.  Within CENTRAL it refers to trials 
using quasi-randomisation, or trials where double blinding was used but randomisation was 
not mentioned.”109 
Randomised controlled trial (RCT) 
 An experiment in which two or more interventions, possibly including a control intervention 
or no intervention, are compared by being randomly allocated to participants.  In most trials 
one intervention is assigned to each individual but sometimes assignment is to defined groups 
of individuals (for example in a household) or interventions are assigned within individuals 
(for example, in different orders or to different parts of the body).
109 
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Appendix 2. Samples of emails sent to 
authors. 
Sample Email 
 
Sent: Fitzgerald Rhian (ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY 
HOSPITALS NHS TRUST) [rhian.fitzgerald@nhs.net] 
To: Anna-Sofia Silvola 
Subject: Early headgear effects on the eruption pattern of maxillary canines 
Dear Dr Silvola, 
 I am conducting a doctorate on the levels of ethical approval and informed consent in 
orthodontic RCTs. I would be grateful if you would answer the following questions on 
your May 2009 Angle Orthodontist article on the effect of early headgear.  
All responses will be treated with utmost confidentiality. 
 1. Has your research obtained ethical approval and or informed consent? 
2. If no, why not? 
3. If yes, why was a statement to that effect not included in the published paper? 
 Thank you very much for your help. If you have any queries please do not hesitate to contact 
me. 
 Kind Regards, 
Rhian Fitzgerald, 
Specialist Registrar in Orthodontics 
University of Liverpool 
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Sample Response 
 
Dear Dr. Rhian Fitzgerald, 
  
1.     The study was initiated 25 years ago, and at that time a written informed consent was 
obtained from the parents with signature, this is archived. 
2.     At that time this procedure in Finland was considered sufficient by the principal 
investigator, Dr. Kantomaa. 
3.     This is published earlier in the papers concerning the same patient material 
“Informed consent was obtained from the parents 
before the randomization. To conceal the allocation, most practitioners who 
performed the treatment were not given information concerning the aim or rationale 
of the study. “Long-term soft-tissue response to orthodontic treatment with early 
cervical headgear--a randomized study.Virkkula T, Kantomaa T, Julku J, Pirttiniemi 
P.Am J Orthod Dentofacial Orthop. 2009 May;135(5):586-96. 
 Best wishes, 
 Pertti Pirttiniemi, Professor and Chair, 
Dpt. of Oral Development and Orthodontics, 
Dean of Faculty, 
Institute of Dentistry, 
P.O.Box 5281, 
FI-90014 University of Oulu, Finland 
+358-8-5375491 
+358-40-5224199 
fax:+358-8-5375503 
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Appendix 3. Raw data for Logistical 
Regression. 
 
Case Processing Summary 
Unweighted Cases
a
 N Percent 
Selected Cases Included in 
Analysis 
218 100.0 
Missing Cases 0 .0 
Total 218 100.0 
Unselected Cases 0 .0 
Total 218 100.0 
a. If weight is in effect, see classification table for the total 
number of cases. 
 
 
Dependent Variable 
Encoding 
Original Value Internal Value 
dimen
sion0 
No 0 
Yes 1 
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Categorical Variables Codings 
 
Frequency 
Parameter coding 
(1) (2) (3) 
journal2 AJODO 119 .000 .000 .000 
AO 38 1.000 .000 .000 
EJO 45 .000 1.000 .000 
JO 16 .000 .000 1.000 
country2 EU 40 .000 .000 .000 
OTHER 71 1.000 .000 .000 
UK 66 .000 1.000 .000 
USA 41 .000 .000 1.000 
numberauthors2 1-3 77 .000 .000  
4-6 122 1.000 .000  
7+ 19 .000 1.000  
numcentres2 1 182 .000 .000  
2 22 1.000 .000  
3+ 14 .000 1.000  
randomtitle2 NO 141 .000   
YES 77 1.000   
randomabstract2 NO 51 .000   
YES 167 1.000   
year2 2005 or before 90 .000   
2006 or later 128 1.000   
 
 
Block 0: Beginning Block 
 
 
 
Classification Table
a,b
 
 Observed Predicted 
 ethicsandconsent Percentage 
Correct  No Yes 
Step 0 ethicsandconsent No 112 0 100.0 
Yes 106 0 .0 
Overall Percentage   51.4 
a. Constant is included in the model. 
b. The cut value is .500 
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Variables in the Equation 
 B S.E. Wald df Sig. Exp(B) 
Step 0 Constant -.055 .136 .165 1 .685 .946 
 
 
Variables not in the Equation 
 Score df Sig. 
Step 0 Variables journal2 13.536 3 .004 
journal2(1) 9.168 1 .002 
journal2(2) 1.902 1 .168 
journal2(3) 4.809 1 .028 
numberauthors2 17.794 2 .000 
numberauthors2(1) 2.977 1 .084 
numberauthors2(2) 17.717 1 .000 
country2 15.736 3 .001 
country2(1) 2.550 1 .110 
country2(2) 10.351 1 .001 
country2(3) 7.573 1 .006 
numcentres2 9.618 2 .008 
numcentres2(1) 5.691 1 .017 
numcentres2(2) 3.115 1 .078 
randomtitle2(1) 14.779 1 .000 
randomabstract2(1) 11.947 1 .001 
year2(1) 8.773 1 .003 
Overall Statistics 51.589 13 .000 
 
 
Block 1: Method = Forward Stepwise (Likelihood Ratio) 
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Omnibus Tests of Model Coefficients 
 Chi-square Df Sig. 
Step 1 Step 14.972 1 .000 
Block 14.972 1 .000 
Model 14.972 1 .000 
Step 2 Step 16.812 2 .000 
Block 31.784 3 .000 
Model 31.784 3 .000 
Step 3 Step 5.677 1 .017 
Block 37.461 4 .000 
Model 37.461 4 .000 
Step 4 Step 6.440 1 .011 
Block 43.901 5 .000 
Model 43.901 5 .000 
Step 5
a
 Step -2.277 1 .131 
Block 41.624 4 .000 
Model 41.624 4 .000 
Step 6 Step 10.084 3 .018 
Block 51.708 7 .000 
Model 51.708 7 .000 
a. A negative Chi-squares value indicates that the Chi-
squares value has decreased from the previous step. 
 
 
Model Summary 
Step -2 Log 
likelihood 
Cox & Snell R 
Square 
Nagelkerke R 
Square 
1 287.075
a
 .066 .089 
2 270.263
b
 .136 .181 
3 264.586
b
 .158 .211 
4 258.146
b
 .182 .243 
5 260.423
b
 .174 .232 
6 250.339
b
 .211 .282 
a. Estimation terminated at iteration number 3 because 
parameter estimates changed by less than .001. 
b. Estimation terminated at iteration number 6 because 
parameter estimates changed by less than .001. 
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Classification Table
a
 
 Observed Predicted 
 ethicsandconsent Percentage 
Correct  No Yes 
Step 1 ethicsandconsent No 86 26 76.8 
Yes 55 51 48.1 
Overall Percentage   62.8 
Step 2 ethicsandconsent No 86 26 76.8 
Yes 48 58 54.7 
Overall Percentage   66.1 
Step 3 ethicsandconsent No 87 25 77.7 
Yes 48 58 54.7 
Overall Percentage   66.5 
Step 4 ethicsandconsent No 73 39 65.2 
Yes 37 69 65.1 
Overall Percentage   65.1 
Step 5 ethicsandconsent No 73 39 65.2 
Yes 37 69 65.1 
Overall Percentage   65.1 
Step 6 ethicsandconsent No 79 33 70.5 
Yes 37 69 65.1 
Overall Percentage   67.9 
a. The cut value is .500 
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Variables in the Equation 
 B S.E. Wald df Sig. Exp(B) 
Step 1
a
 randomtitle2(1) 1.121 .296 14.293 1 .000 3.067 
Constant -.447 .173 6.703 1 .010 .640 
Step 2
b
 numberauthors2   7.906 2 .019  
numberauthors2(1) -.045 .301 .023 1 .880 .956 
numberauthors2(2) 2.905 1.061 7.505 1 .006 18.273 
randomtitle2(1) .993 .308 10.409 1 .001 2.700 
Constant -.535 .259 4.258 1 .039 .585 
Step 3
c
 numberauthors2   8.295 2 .016  
numberauthors2(1) -.028 .305 .008 1 .927 .972 
numberauthors2(2) 3.022 1.072 7.941 1 .005 20.527 
randomtitle2(1) .714 .329 4.721 1 .030 2.042 
randomabstract2(1) .910 .394 5.336 1 .021 2.485 
Constant -1.165 .389 8.975 1 .003 .312 
Step 4
d
 numberauthors2   8.372 2 .015  
numberauthors2(1) -.036 .310 .013 1 .909 .965 
numberauthors2(2) 3.045 1.077 7.990 1 .005 21.012 
randomtitle2(1) .517 .343 2.275 1 .131 1.678 
randomabstract2(1) 1.004 .404 6.186 1 .013 2.730 
year2(1) .788 .314 6.306 1 .012 2.199 
Constant -1.637 .443 13.679 1 .000 .195 
Step 5
d
 numberauthors2   9.223 2 .010  
numberauthors2(1) -.051 .308 .027 1 .869 .950 
numberauthors2(2) 3.171 1.073 8.739 1 .003 23.841 
randomabstract2(1) 1.227 .379 10.499 1 .001 3.412 
year2(1) .899 .305 8.659 1 .003 2.457 
Constant -1.697 .444 14.608 1 .000 .183 
Step 6
e
 journal2   9.248 3 .026  
journal2(1) -.701 .450 2.432 1 .119 .496 
journal2(2) .531 .394 1.813 1 .178 1.701 
journal2(3) 1.294 .668 3.756 1 .053 3.648 
numberauthors2   8.691 2 .013  
numberauthors2(1) .115 .326 .125 1 .724 1.122 
numberauthors2(2) 3.182 1.082 8.642 1 .003 24.099 
randomabstract2(1) 1.080 .392 7.602 1 .006 2.946 
year2(1) 1.000 .317 9.942 1 .002 2.718 
Constant -1.825 .507 12.986 1 .000 .161 
a. Variable(s) entered on step 1: randomtitle2. 
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b. Variable(s) entered on step 2: numberauthors2. 
c. Variable(s) entered on step 3: randomabstract2. 
d. Variable(s) entered on step 4: year2. 
e. Variable(s) entered on step 6: journal2. 
 
Variables in the Equation 
 
95% C.I.for EXP(B) 
Lower Upper 
Step 1
a
 randomtitle2(1) 1.716 5.484 
Constant   
Step 2
b
 numberauthors2   
numberauthors2(1) .530 1.724 
numberauthors2(2) 2.286 146.069 
randomtitle2(1) 1.477 4.937 
Constant   
Step 3
c
 numberauthors2   
numberauthors2(1) .535 1.768 
numberauthors2(2) 2.509 167.922 
randomtitle2(1) 1.072 3.889 
randomabstract2(1) 1.148 5.381 
Constant   
Step 4
d
 numberauthors2   
numberauthors2(1) .526 1.772 
numberauthors2(2) 2.544 173.555 
randomtitle2(1) .856 3.287 
randomabstract2(1) 1.237 6.024 
year2(1) 1.189 4.067 
Constant   
Step 5
d
 numberauthors2   
numberauthors2(1) .520 1.738 
numberauthors2(2) 2.912 195.207 
randomabstract2(1) 1.624 7.168 
year2(1) 1.350 4.471 
Constant   
Step 6
e
 journal2   
journal2(1) .205 1.197 
journal2(2) .785 3.683 
journal2(3) .985 13.503 
numberauthors2   
numberauthors2(1) .592 2.128 
numberauthors2(2) 2.888 201.101 
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randomabstract2(1) 1.367 6.349 
year2(1) 1.460 5.061 
Constant   
a. Variable(s) entered on step 1: randomtitle2. 
b. Variable(s) entered on step 2: numberauthors2. 
c. Variable(s) entered on step 3: randomabstract2. 
d. Variable(s) entered on step 4: year2. 
e. Variable(s) entered on step 6: journal2. 
 
 
Model if Term Removed 
Variable 
Model Log 
Likelihood 
Change in -2 
Log 
Likelihood df 
Sig. of the 
Change 
Step 1 randomtitle2 -151.024 14.972 1 .000 
Step 2 numberauthors2 -143.537 16.812 2 .000 
randomtitle2 -140.483 10.703 1 .001 
Step 3 numberauthors2 -141.072 17.559 2 .000 
randomtitle2 -134.689 4.793 1 .029 
randomabstract2 -135.131 5.677 1 .017 
Step 4 numberauthors2 -137.931 17.716 2 .000 
randomtitle2 -130.212 2.277 1 .131 
randomabstract2 -132.394 6.642 1 .010 
year2 -132.293 6.440 1 .011 
Step 5 numberauthors2 -140.401 20.379 2 .000 
randomabstract2 -136.031 11.638 1 .001 
year2 -134.689 8.956 1 .003 
Step 6 journal2 -130.212 10.084 3 .018 
numberauthors2 -134.401 18.462 2 .000 
randomabstract2 -129.271 8.203 1 .004 
year2 -130.378 10.416 1 .001 
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Variables not in the Equation 
 Score df Sig. 
Step 1 Variables journal2 7.799 3 .050 
journal2(1) 5.852 1 .016 
journal2(2) 1.519 1 .218 
journal2(3) 1.581 1 .209 
numberauthors2 13.955 2 .001 
numberauthors2(1) 1.967 1 .161 
numberauthors2(2) 13.929 1 .000 
country2 7.137 3 .068 
country2(1) .369 1 .543 
country2(2) 3.487 1 .062 
country2(3) 4.222 1 .040 
numcentres2 4.664 2 .097 
numcentres2(1) 2.595 1 .107 
numcentres2(2) 1.491 1 .222 
randomabstract2(1) 4.814 1 .028 
year2(1) 5.513 1 .019 
Overall Statistics 39.611 12 .000 
Step 2 Variables journal2 6.983 3 .072 
journal2(1) 4.885 1 .027 
journal2(2) 1.244 1 .265 
journal2(3) 1.821 1 .177 
country2 6.859 3 .077 
country2(1) .033 1 .856 
country2(2) 2.377 1 .123 
country2(3) 5.098 1 .024 
numcentres2 3.470 2 .176 
numcentres2(1) 3.365 1 .067 
numcentres2(2) .030 1 .863 
randomabstract2(1) 5.495 1 .019 
year2(1) 5.479 1 .019 
Overall Statistics 27.059 10 .003 
Step 3 Variables journal2 6.198 3 .102 
journal2(1) 3.698 1 .054 
journal2(2) 1.482 1 .223 
journal2(3) 1.791 1 .181 
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country2 6.717 3 .081 
country2(1) .095 1 .758 
country2(2) 1.389 1 .239 
country2(3) 6.072 1 .014 
numcentres2 2.459 2 .292 
numcentres2(1) 2.430 1 .119 
numcentres2(2) .001 1 .977 
year2(1) 6.424 1 .011 
Overall Statistics 21.782 9 .010 
Step 4 Variables journal2 8.099 3 .044 
journal2(1) 4.219 1 .040 
journal2(2) 1.882 1 .170 
journal2(3) 2.792 1 .095 
country2 7.095 3 .069 
country2(1) .050 1 .823 
country2(2) 2.485 1 .115 
country2(3) 5.257 1 .022 
numcentres2 2.099 2 .350 
numcentres2(1) 1.728 1 .189 
numcentres2(2) .258 1 .612 
Overall Statistics 15.755 8 .046 
 
Step 5
a
 Variables journal2 9.802 3 .020 
journal2(1) 4.840 1 .028 
journal2(2) 2.150 1 .143 
journal2(3) 4.032 1 .045 
country2 9.030 3 .029 
country2(1) .305 1 .581 
country2(2) 3.870 1 .049 
country2(3) 6.391 1 .011 
numcentres2 2.720 2 .257 
numcentres2(1) 2.266 1 .132 
numcentres2(2) .316 1 .574 
randomtitle2(1) 2.291 1 .130 
Overall Statistics 17.950 9 .036 
 
Step 6
a
 Variables country2 6.591 3 .086 
country2(1) .002 1 .963 
country2(2) .958 1 .328 
country2(3) 5.448 1 .020 
numcentres2 2.618 2 .270 
146 
 
numcentres2(1) 1.964 1 .161 
numcentres2(2) .490 1 .484 
randomtitle2(1) .498 1 .480 
Overall Statistics 8.317 6 .216 
a. Variable(s) removed on step 5: randomtitle2. 
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Ethical 
Approval 
Informed 
Consent 
13 
32 
8 
36 
Appendix 4. Additional Figures for 
Results 
Figure 1. RCTs with ethical approval and informed consent 
 
 
Figure 2. Percentage of CCTs with ethical approval and informed consent. 
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Figure 3. Percentage of RCTs and CCTs with ethical approval and informed 
consent. 
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Figure 4. Journal of Publication and percentage of RCTs with ethical approval 
and informed consent or not. 
 
 
Figure 5. Number of Authors and percentage of RCTs with ethical approval 
and informed consent or not. 
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Figure 6. Number of Centres and percentage of RCTs with ethical approval 
and informed consent or not. 
 
Figure 7. Location of Origin and percentage of RCTs with ethical approval and 
informed consent or not. 
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Figure 8. Involvement of a statistician and percentage of RCTs with ethical 
approval and informed consent or not. 
 
 
Figure 9. Year of publication and percentage of RCTs with ethical approval 
and informed consent or not.       
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Figure 10. Percentage of RCTs with random* in the title and ethical approval 
and informed consent or not. 
 
Figure 11. Percentage of RCTs with random in the abstract but not title with 
ethical approval and informed consent or not. 
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Figure 12. Number of RCTs found and missed by all four search methods. 
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Appendix 5. Regularity of journal publication 
Month     Year      
 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 
Jan AJODO AJODO AJODO AJODO AJODO, AO AJODO, AO AJODO, AO AJODO, AO AJODO, AO AJODO, AO 
Feb AJODO, 
AO, EJO 
AJODO, AO, 
EJO 
AJODO, AO, 
EJO 
AJODO, AO, 
EJO 
AJODO, EJO AJODO, EJO AJODO, EJO AJODO, EJO AJODO, EJO AJODO, 
EJO, EJO 
Mar AJODO, JO AJODO, JO AJODO, JO AJODO, JO AJODO, AO, JO AJODO, AO, 
JO 
AJODO, AO, 
JO 
AJODO, AO, 
JO 
AJODO, AO, 
JO 
AJODO, AO, 
JO 
Apr AJODO, 
AO, EJO 
AJODO, AO, 
EJO 
AJODO, AO, 
EJO 
AJODO, AO, 
EJO 
AJODO,EJO AJODO, 
AJODO, EJO 
AJODO, 
AJODO, 
EJO, EJO 
AJODO, 
AJODO, EJO 
AJODO, 
AJODO, EJO 
AJODO, 
AJODO, EJO 
May AJODO AJODO AJODO AJODO AJODO, AO AJODO, AO AJODO, AO AJODO, AO AJODO, AO AJODO, AO 
June AJODO, 
AO, EJO, 
JO  
AJODO, AO, 
EJO, JO 
AJODO, AO, 
EJO, JO 
AJODO, AO, 
EJO, JO 
AJODO, EJO, JO AJODO, 
EJO, JO 
AJODO, 
EJO, JO 
AJODO, 
EJO, JO 
AJODO, 
EJO, JO 
AJODO, 
EJO, JO 
July AJODO AJODO AJODO AJODO AJODO, AO AJODO, AO AJODO, AO AJODO, AO AJODO, AO AJODO, AO 
Aug AJODO, 
AO, EJO 
AJODO, AO, 
EJO 
AJODO, AO, 
EJO 
AJODO, AO, 
EJO 
AJODO, EJO AJODO, EJO AJODO, EJO AJODO, EJO AJODO, EJO AJODO, EJO 
Sept AJODO, JO AJODO, JO AJODO, AO, 
JO 
AJODO, JO AJODO, AO, JO AJODO, AO, 
JO 
AJODO, AO, 
JO 
AJODO, AO, 
JO 
AJODO, AO, 
JO 
AJODO, AO, 
JO 
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Oct AJODO, 
AO, EJO 
AJODO, AO, 
EJO 
AJODO, EJO AJODO, AO, 
EJO 
AJODO, EJO AJODO, EJO AJODO, EJO AJODO, EJO AJODO, EJO AJODO, EJO 
Nov AJODO AJODO AJODO AJODO AJODO, AO AJODO, AO AJODO, AO AJODO, AO AJODO, AO AJODO, AO 
Dec AJODO, 
AO, EJO, 
JO 
AJODO, AO, 
EJO, JO 
AJODO, AO, 
EJO, JO 
AJODO, AO, 
EJO, JO 
AJODO, EJO, JO AJODO, 
EJO, JO 
AJODO, 
EJO, JO 
AJODO, 
EJO, JO 
AJODO, 
EJO, JO, JO 
AJODO, 
EJO, JO 
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